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Abstract 
Antimicrobials are pharmaceutically active compounds that destroy or inhibit the growth of bacteria, 
fungi, protozoa, or viruses. This diverse group of compounds, used in both humans and livestock, are 
increasingly being detected in the environment, especially in soil and aquatic ecosystems. Their 
widespread environmental occurrence is being linked to the potential development of resistance traits 
in microorganisms, which is a serious threat to global health. Quantifying this health risk is difficult 
due to the lack of available data on the consumption of antimicrobials, as well as the varying 
regulations on their use and distribution. Further, the environmental fate and occurrence of these 
chemicals in watersheds is complex and poorly understood. The current research aims to address this 
knowledge gap by examining the occurrence and distribution of select antimicrobials in a watershed 
through modeling and empirical data collection (survey). It achieves this goal by addressing the 
following objectives: (1) to develop a mass load model for estimating the residual concentrations of 
veterinary antimicrobials; and (2) evaluate the occurrence and sources of select antimicrobials in 
surface waters. The Grand River Watershed, a mixed-use watershed in Southern Ontario, Canada, 
was selected as the study site. 
 
The mass load model was used to estimate the residual concentrations of four veterinary 
antimicrobials (lincomycin, monensin, oxytetracycline, and sulfamethazine) in the soil and water 
matrices. Predicted antimicrobial concentrations ranged from 0.1 μg/kg (monensin and 
oxytetracycline) to 60 μg/kg in soil (sulfamethazine) and 37 pg/L (oxytetracycline) to 18 μg/L 
(sulfamethazine) in surface water. Estimated antimicrobial concentrations were highest in sub-basins 
with high livestock densities, with the highest predicted levels found in the Nith sub-basin where 
there is intensive livestock production.  
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For the occurrence survey in the Grand River Watershed, triplicate water samples were collected from 
27 sites in the main channel, one location each in five tributaries, and seven wastewater treatment 
plant (WWTP) effluents. Temporal sampling was also performed in six additional sites (four in an 
agricultural tributary and two in the main channel). The water samples were analyzed for five 
antimicrobials (sulfamethazine, sulfamethoxazole, trimethoprim, lincomycin, and monensin), and 
three chemical indicators (venlafaxine, ibuprofen, and atrazine). In the main channel, measured 
concentrations of target analytes exhibited an increasing trend from the headwaters to downstream 
towards the discharge point to Lake Erie. Peak concentrations measured in the river water were 98  
8.8 ng/L for antimicrobials (sulfamethazine) and 146  67 ng/L for the indicators (ibuprofen). In the 
effluents, the highest measured concentrations were 355  126 ng/L for sulfamethoxazole and 349  
11 ng/L for ibuprofen. Atrazine was found at low concentrations throughout the river samples but was 
not found in the wastewater effluents. Lincomycin was found in only a few samples and monensin 
was not found in any samples. Based on an analysis of the measured analyte concentrations, non-
point sources were likely the main source of sulfamethazine in the main channel, while wastewater 
discharges were the main sources of sulfamethoxazole and trimethoprim. Sulfamethazine was 
detected at lower concentrations (8.8-65 ng/L) during the temporal sampling than during the large-
scale sampling (peak concentration of 98 ± 8.8 ng/L), suggesting the significance of timing when 
collecting field samples for monitoring purposes.  
 
Results from the model estimation suggest that livestock operations can be important sources of 
antimicrobials in receiving waters. Results of the survey sampling in the Grand River Watershed also 
suggest that agricultural sources and WWTP discharges are important sources of antimicrobials in the 
watershed.  Over-all, none of the measured antimicrobial concentrations were above the 1 μg/L risk 
  v 
threshold (for water) recommended by the Committee for Medicinal Products for Veterinary Use 
(CVMP).  As tighter regulations on the use of antimicrobials emerge in Canada, and as more WWTP 
upgrades are completed in the Grand River Watershed, the findings of the current study can serve as 
baseline for determining the future impacts of these regulatory and infrastructure changes.  
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Chapter 1: Introduction 
This chapter provides a background to the research presented in this manuscript. It gives an overview of 
the consumption, environmental occurrence, and regulation of antimicrobials from global and Canadian 
perspectives. The chapter is organized into sections covering the following topics: 1) the global 
consumption of antimicrobials in livestock production and in human medication; 2) critical issues related 
to the widespread use of antimicrobials and the development of resistant traits in bacteria; 3) the 
environmental occurrence of veterinary antimicrobials as reported in literature; 4) recent global regulations 
on the control and consumption of antimicrobials, and 5) epilogue. The chapter concludes by defining the 
motivation, scope, and objectives for the current research. 
1.1 Global Use and Consumption of Antimicrobials 
Antimicrobials are pharmaceutically active compounds that destroy or inhibit the growth of bacteria, fungi, 
protozoa, or viruses. They are similar in function to antibiotics but are distinct from the latter because 
antibiotics do not fight against viruses (Kümmerer, 2009). Antimicrobials are ubiquitous in the 
environment largely due to their extensive use in livestock husbandry, in human medication, and in general 
antibacterial protection.  
1.1.1 Administration in Livestock 
In livestock farming, antimicrobials are administered to animals in four ways to reduce the risks of 
infections, decrease mortality, sustain growth, and increase production. These four treatments are: therapy, 
prophylaxis, metaphylaxis, and growth promotion. Therapy involves the treatment of infected livestock 
with antimicrobials until the infection is relieved. Prophylaxis is used as a control method for herds 
experiencing abnormally high death rates. Metaphylaxis is a preventative treatment for at-risk but disease-
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free livestock. Finally, growth promotion is administered to prevent the onset of disease and to increase 
feed efficiency (Guardabassi et al., 2008; Kemper, 2008). Of these four types of treatment, growth 
promotion uses the most antimicrobials due to the longer duration of treatment and the larger livestock 
populations involved. In this treatment, an entire herd is dosed with low concentrations of antimicrobials, 
either through feed or water, to promote growth and nutrient assimilation in the body. When administered 
through feed, the antimicrobial concentrations are typically below 200 g/tonne
 
of feed. To be considered a 
growth promoter, the antimicrobial must be administered for a period longer than fourteen days (Graham 
et al., 2007).   
 
It has been argued that the increased use of antimicrobials in growth promotion has led to a subsequent 
increase in antimicrobial resistance (AMR) (McEwen, 2012; Witte, 2000). Antimicrobial growth 
promoters are also considered to be the main contributors to selective resistance in bacteria (Topp et al., 
2012). Further, it has been suggested that international trading in the modern economy may induce the 
global transfer and development of AMR through the exportation and importation of animal products 
among countries (Maron et al., 2013; O’Brien, 2002). In this context, a country’s efforts to control AMR 
through strict regulations on antimicrobials use may be undermined when contaminated products are 
imported from other countries without similar policies. Therefore, in formulating strategies for managing 
the spread of AMR, it is also important to consider national laws on antimicrobials use, per country 
consumption of antimicrobials, and the international trade flows of agricultural products (Cabello et al., 
2013).  
 
Monitoring the worldwide consumption of antimicrobials can be very challenging due to the large 
variability in the methodologies for data collection and synthesis among countries. Antimicrobials 
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consumption in the livestock industry is usually inferred from sales data or from estimates of livestock 
treatment doses (EMA, 2013). However, the available data can be inconsistent and often do not distinguish 
between imported and exported antimicrobials. The frequency of data reporting is also highly variable and, 
in general, very limited. The data shown in Table 1-1 were obtained by mining data in the database links 
listed by Page and Gautier (2012) and through literature search (covered period 2000-2014) in the Web of 
Science and Google Scholar using the combined keywords “antimicrobials”, “antibiotics”, “veterinary”, 
“sales”, and “country”. As seen in Table 1-1, European countries report sales data on a more regular basis 
compared to the rest of the world. This systematic effort to consolidate sales data in Europe stems from the 
region’s tighter regulations on the use of antimicrobials in their livestock industry. It is notable that data 
are unavailable for many countries in the larger and agriculture-dependent regions of Africa, Asia, 
Australia and Oceania, the Middle East, and South America. More importantly, consumption data, either 
from literature or from government agencies, are not readily available for most countries that are among 
the top livestock producers in the global market. Of the countries listed as top global producers of eleven 
livestock groups in Table 1-2, less than 15% have multi-year sales data (i.e., at least 2 years of reporting 
frequency) on veterinary antimicrobials since 2005 (Table 1-1). Eight countries are also the largest 
producers of at least five livestock groups; these are: China (9 groups), India (7 groups), Brazil (6 groups), 
Pakistan (6 groups), Ethiopia (5 groups), Mexico (5 groups), the Russian Federation (5 groups) and the 
United States (US, 5 groups). Of these countries, only the US currently reports antimicrobial consumption 
regularly in its livestock industry.  
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Table 1-1: Global Consumption of Veterinary Antimicrobials
 
 Average
a
2005 2006 2007 2008 2009 2010 2011 2012
Africa South Africa
b
1,538 - - - - - - - - Eagar et al., 2012
Ethiopia
c 416 - - - - - - - - Embassy of Ethiopia, 2012
Kenya
d 14.6 - - - - - - - - Mitema et al., 2001
Asia China
e 6,000
m
- - 96,810 - - - - - Zhao et al., 2010; Hvistendahl, 2012
Korea
f 1,533 - - - - - - - - Kim et al., 2011
Japan
g 870 - - - - - - - - JVARM, 2013
Australia Australia
h 452
n
- 655 572 580 482 644 - - JETACAR, 1999; APVMA, 2014
and Oceania New Zealand
i - 53 63 56 53 56 - - - MAF, 2011
Europe Germany - - - - - - - 1,819 1,708 EMA, 2013, 2014
j
Spain - - - - - - 1,746 1,779 1,693 EMA, 2013, 2014 
Italy - - - - - - 1,928 1,663 1,534 EMA, 2013, 2014 
France - 1,322 1,260 1,346 1,188 1,064 997 896 762 EMA, 2011, 2013, 2014 
Poland - - - - - - - 471 516 EMA, 2013, 2014 
United Kingdom - 445 403 395 381 403 456 344 447 EMA, 2011, 2013, 2014 
Belgium - - - - - - 299 297 267 EMA, 2013, 2014 
Netherlands - 508 544 589 525 514 461 363 246 EMA, 2011, 2013, 2014 
Hungary - - - - - - 206 147 179 EMA, 2013, 2014 
Portugal - - - - - - 181 164 157 EMA, 2013, 2014 
Denmark - 111 114 119 117 129 119 106 107 EMA, 2011, 2013, 2014 
Ireland - - - - - - 96 87 100 EMA, 2013, 2014 
Switzerland - - 68 72 73 71 - - - EMA, 2013, 2014 
Czech Republic - 91 100 88 95 82 71 61 54 EMA, 2011, 2013, 2014 
Austria - - - - - - 63 53 53 EMA, 2013, 2014 
Cyprus - - - - - - - 52 45 EMA, 2013, 2014 
Bulgaria - - - - - - - 42 38 EMA, 2013, 2014 
Lithuania - - - - - - 16 14 13 EMA, 2013, 2014 
Finland - 14 14 15 17 17 13 12 12 EMA, 2011, 2013, 2014 
Sweden - 16 17 17 16 15 13 11 11 EMA, 2011, 2013, 2014 
Slovakia - - - - - - - 11 10 EMA, 2013, 2014 
Estonia - - - - - - 7.6 7.5 7.3 EMA, 2013, 2014 
Norway - 6.3 6.4 6.3 6.2 6.1 6.2 6.3 7.1 EMA, 2011, 2013, 2014 
Slovenia - - - - - - 8.4 7.8 6.8 EMA, 2013, 2014 
Latvia - - - - - - 6.6 6.0 6.7 EMA, 2013, 2014 
Luxembourg - - - - - - - - 2.2 EMA, 2014
Iceland - - - - - - 0.9 0.7 0.7 EMA, 2013, 2014 
Middle East Iran - - - - - - 1,807 - - Aalipour et al., 2014
North America United States - - - - - 12,790 13,506 13,771 14,758 US FDA, 2010, 2011, 2012a, 2014
k
Canada - - 1,766 1,618 1,616 - - - - CIPARS, 2011
South America Chile
l - - - 930 - - - - - Cabello et al., 2013
a) Unless otherwise indicated, averaging period is unknown.
b) Yearly average: 2002 - 2004.
c) Value includes antibiotics, anthelmentics, and antiprotozoals, estimate is for 2012.
d) Annual mean quantities of antimicrobials administered to food producing animals between 1995-1999. 
e) Prior to 2003, exact year not specified.
f) Prior to 2006, exact year not specified.
g) Yearly average: 2004-2010.  
h) Data recorded from July 2005 to June 2010. Data in this table use the latter calendar year as reporting year (i.e. 2005/2006 data represented as 2006)
i) Data recorded from 1 April of current year to 31 March of following year. 
Data in this table use the the latter calendar year as reporting year (i.e., 2005/2006 data represented as 2006). 
j) EMA values are sales of antimicrobials for food producing animals and horses.
k) Includes domestic sales as well as export sales for food producing and non-food producing animals.
l) Includes only imported antimicrobials from  tetracycline, florfenicol and quinolones classes, used mostly in salmon aquaculture.
m) Not specified if in short tons, long tons, or metric tonnes.
n) Yearly average of imported veterinary antimicrobials: 1992-1997.
ReferenceRegion Country
Sales (Tonnes) by Year
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Table 1-2: Top Global Producers of Livestock 
 
In addition to the variability in data reporting frequencies, there is also the issue of inconsistencies in data 
collection methodologies. For example, the Canadian data include sales of antimicrobials for food 
producing, sporting, and companion animals as well as fish stocks (CIPARS, 2011a). In contrast, European 
data include only the antimicrobials used in food-producing animals and horses (EMA, 2013). In general, 
reported sales data from most countries exclude antimicrobials used in farming aquatic stock such as 
salmon or shrimp (Cabello et al., 2013). 
 
Standardized data collection methods and frequencies are critical in monitoring the global use of 
antimicrobials and its relationship with antimicrobial resistance. Consistent regional data aids researchers 
and policymakers in determining changes in the livestock population fluxes, trends in antimicrobial 
consumption, yearly variations in farming practices, and the effects of changes in legislation. Thus, it is 
important to have regular data collection to establish benchmarks and evaluate if strategies for curbing 
 6 
 
antimicrobials use have the desired effects in controlling AMR. The European method for data collection 
and reporting is a good starting template for many countries. The consistency of data from European 
countries allows for the monitoring of antimicrobial consumption by class and livestock, and enables better 
identification of the critical antimicrobials that need to be monitored in relation to the control of 
antimicrobial resistance. 
1.1.2 Administration in Humans 
Penicillin and streptomycin were the first antimicrobials developed and administered to humans in the 
1930s to fight against infections (Kumar et al., 2012). To date, there are approximately 3000 medicinal 
products with 250 pharmaceutically active compounds available for use as antimicrobials (Kumar et al., 
2012; Kümmerer and Henninger, 2003). Each year, it is estimated that between 100,000 – 200,000 tonnes 
of these compounds are produced worldwide to treat humans and animals (Wise, 2002).   
In most countries, antimicrobials for human medication can only be obtained through prescription; thus, 
the human consumption of antimicrobials has mostly been inferred from the number of dispensed 
prescriptions or sales data. Historical data on consumption is more readily available for the European 
region, which is also the first to regulate the use of certain antimicrobials in human and veterinary 
applications. Figure 1-1 shows the consumption of antimicrobials in Europe and in Canada in the period 
2000-2009. The data are reported in units of defined daily doses (DDD), which is the average equivalent 
daily dose per patient. The European data are based on the number of outpatients while the Canadian data 
are based on sales. Except for a slight increase in 2003, antimicrobials consumption in Europe decreased 
from 2000 through 2004, and has since exhibited an increase until 2008. The Canadian sales also 
decreased through 2004, followed by an increase in 2006, and has since been approximately constant 
through 2009. There were no easily identifiable causes (e.g., infection epidemic, regulations) for the 
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fluctuations in use in Canada (Finley et al., 2013). In all years, the Canadian sales are below the average 
European consumption.  
 
Figure 1-1: European Average Consumption and Canadian Sales of Antimicrobials per 1,000 
Inhabitants from 2000-2009.  Data were Compiled Following the J01 Classification (Antibacterials 
for Systemic Use) of the Anatomical Therapeutic Chemical Classification System Commended by 
the World Health Organization (CIPARS, 2011b; ESAC, 2009). 
 
Recent data from Canada suggests that the human use of antimicrobials is considerably less than that in 
livestock production (Figure 1-2). From 2006-2009, human consumption (1600-1800 tonnes/year) 
accounts for approximately 10% of the total antimicrobials sold in Canada. This value is significantly less 
than estimates from previous researchers (50-50 split, Hughes and Heritage, 2004) The sales data for 
livestock production do not include antimicrobials brought into Canada through unregistered cross-border 
importation (discussed in Section 1.4), which is estimated to increase antimicrobials use in livestock by 
25% (Prescott and Szkotnicki, 2012).  
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Figure 1-2: Canadian Antimicrobial Sales for Human and Animal Use as Reported by the Canadian 
Integrated Program for Antimicrobial Resistance between 2006-2008 (CIPARS, 2011a; CIPARS 
2011b). 
 
1.2 Antimicrobial Resistance 
The global demand for meat products has increased in the last few decades, leading to a rise in animal 
production and antimicrobial administration. The annual per capita meat consumption rose from 24 kg in 
the mid-1960s to 36 kg in the late 1990s, and is estimated to rise again to 45 kg in 2030 (Bruinsma, 2003). 
Consequently, the densities of livestock in farms and the use of antimicrobials in animals have also 
increased to meet demand (Tilman et al., 2002). Researchers have raised concerns over the widespread use 
of veterinary antimicrobials due to the potential for developing AMR in bacteria (Alexander et al., 2008; 
Diarra et al., 2007; van den Bogaard and Stobberingh, 2000; Witte, 1998). Steadily feeding antimicrobials 
to animals at low doses may induce resistant traits in zoonotic and commensal bacteria (McEwen, 2012). 
The infected livestock can therefore act as reservoirs for resistant pathogens that can be transferred to 
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humans (Kemper, 2008). This can occur through cross-resistance, where a resistant strain develops 
resistance to an antimicrobial from the same class due to similarities in molecular structure, or through co-
selection, where the same resistant gene has multiple resistant mutations that apply to multiple classes. To 
date, several laboratory and field studies have been performed to demonstrate the effects of antimicrobials 
exposure on bacteria. Increases in the prevalence of antibacterial-resistant populations have been observed 
in many cases (Vasquez et al., 2014; Gullberg et al., 2011; Liu et al., 2011; Costanzo et al., 2005). 
The role of resistance transfer from companion animals (e.g., dogs and cats) to humans is not well 
understood but is a potential threat to human health (Jensen et al., 2008). The risk is attributed to the use of 
critical broad-spectrum antimicrobials in humans and in companion animals. For example, a 2003 study 
found methicillin-resistant Staphylococcus aureus (MRSA) in both a human patient and his dog, 
presenting a case of potential spread of the disease from the pet to the owner (Manian, 2003). 
 
Resistant bacterial strains can also spread through the food chain, through direct contact with infected 
animals, and through indirect pathways in the environment. Quantifying the AMR transmission rates 
across these pathways can be challenging due to the high number of factors and variables involved in the 
process. The contribution of contaminated livestock manure and wastewater effluent to AMR transmission 
is not well understood because it is difficult to ascertain whether bacteria were already resistant before 
entering the natural environment or at what point in the AMR transmission chain the bacteria became 
resistant (Kümmerer, 2004). Despite this uncertainty, there is evidence in literature that suggests AMR 
development in human pathogens. A study by Finley et al., (2013a) found that human pathogens can 
acquire resistance genes through environmental exposure. Resistant bacteria, e.g., E. coli, have also been 
detected in drinking water sources and even in tap water (CIPARS, 2012a; CBC News, 2009). There is 
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also a marked rise in some cases of highly resistant pathogens, for example, MRSA rates in Canadian 
hospitals rose over ten-fold in the period 1995-2003 (Public Health Agency of Canada, 2005).  
The study of AMR development and transmission in an ecosystem is a difficult undertaking due to the 
large number of variables involved and the complexity of the relationships among these variables. 
Generally there is a poor understanding of how bacterial resistance spreads in diverse ecosystems where 
multiple selective pressures are present (Cabello et al., 2013). A multi-variable AMR transmission study is 
resource-intensive and may involve the simultaneous determination of the rates of contact, transfer, 
integration, replication, diversification, and selection of resistant traits in bacteria and other organisms as 
they interact within a range of conditions (Martinez and Baquero, 2014).  Monitoring these variables 
simultaneously can help identify specific factors that induce or inhibit AMR spread in the environment; 
however, this task is difficult to perform due to its complexity and cost. Despite this limitation, it is 
possible to infer AMR transmission trends from long-term and well-designed surveillance studies. 
Findings from a multi-year surveillance study of ceftiofur use in poultry have shown a strong correlation 
between ceftiofur and the development of ceftiofur-resistant strains of E. coli and S. enterica in humans 
(Dutil et al., 2010). The authors concluded that resistant bacterial strains that developed in chicken eggs 
were eventually transmitted to humans through retail chicken meat. They also suggested that this outcome 
could be attributed to the extra-label drug use (ELDU) for ceftiofur. Medication that is labeled ELDU can 
be used for treatment purposes other than those indicated on their prescription label.  
 
The Dutil et al., (2010) study demonstrates cross-selection where the increased bacterial resistance to 
ceftiofur can potentially induce cross-resistance to other antimicrobials from the cephalosporin class that 
are commonly used to treat human infections. For this reason, the World Health Organization classifies 
ceftiofur as a Level I antimicrobial, or antimicrobials that are important in human medication (WHO, 
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2007). This classification was the basis for a recent decision by the US Food and Drug Administration 
(FDA) to ban the ELDU for cephalosporins (Prescott and Szkotnicki, 2012). In contrast, Health Canada 
only recommends avoiding ELDU labels for cephalosporins (Health Canada, 2008).  
1.3 Environmental Occurrence 
Residual antimicrobials in the environment are xenobiotic and thus can often be traced back to their 
sources. Point source contributions from wastewater treatment plant (WWTP) effluents are associated with 
prescription medication for humans. Non-point residual antimicrobials originate from agriculture, either 
through the discharge of contaminated wastewater, surface run-off, or through land application of 
contaminated manure (Yang et al., 2010; Christian et al., 2003). Accounting for non-point source 
contributions of antimicrobials can be challenging due to the high variability in their usage rates and 
dosages administered to livestock.  Some agricultural practices (e.g., composting) can also compound 
tracking problems due to the transfer of antimicrobials between environmental matrices.  
The majority of antimicrobial drugs are poorly metabolized in animals, and un-metabolized residuals are 
excreted in the feces and urine. For example, excretion rates for chlortetracycline, sulfamethazine and 
tylosin can range between 50% and 100% of their original doses  (Sarmah et al., 2006; Thiele-Bruhn, 
2003). Excreted antimicrobials can degrade, adsorb to soil, assimilate into plants, leach to groundwater, 
and run-off into surface water (Blackwell et al., 2007; Dolliver et al., 2007; Kreuzig and Höltge, 2005; 
Migliore et al., 1996). Literature data indicate that the environmental mobility of most antimicrobials is 
correlated with soil–compound interactions rather than with hydrophobicity alone (Tolls, 2001). Most 
antimicrobials bind strongly to soil and resist degradation (Kumar et al., 2005). Multiple studies have 
shown that detected concentrations of antimicrobials in surface water (ppt to ppb range) are significantly 
below minimum inhibitory concentrations for aquatic organisms (Wei et al., 2011; Boxall et al., 2005; 
Kolpin et al., 2002; Hirsch et al., 1999). 
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In Canada, despite the existence of intensive livestock production in large agricultural areas, there has not 
been any large-scale reconnaissance study for surface waters similar to that done by Kolpin et al. (2002) in 
the United States. The majority of environmental occurrence surveys of antimicrobials focus on 
wastewater effluents and antimicrobials for human medication. For example, Miao et al., (2004) surveyed 
eight WWTPs in five Canadian cities and frequently detected clarithromycin, erythromycin, 
roxithromycin, ciprofloxacin, ofloxacin, sulfamethoxazole, sulfapyridine, and tetracycline in the effluents. 
Guerra et al., (2014) also found human antimicrobials in five WWTP effluents over a two-year sampling 
period during summer and winter. Detected antimicrobials included azithromycin (210 ng/L), 
clarithromycin (1,100 ng/L), erythromicyn-H2O (96 ng/L), ofloxacin (45 ng/L), and trimethoprim (170 
ng/L). Human antimicrobials have also been detected in surface waters receiving WWTP effluents. Waiser 
et al., (2011) measured twelve antimicrobials including trimethoprim, sulfamethoxazole, amoxicillin, and 
triclosan at five locations along Wascana Creek in Saskatchewan. In this study, trimethoprim was detected 
as far as 60 km downstream from the WWTP. 
 
Two Canadian studies have reported the detection of veterinary antimicrobials in surface water. Lissemore 
et al., (2006) conducted biweekly sampling over summer and spring at eight locations along the Grand 
River in Southern Ontario that have historically been susceptible to agricultural runoff. The antimicrobials 
frequently detected were lincomycin, monensin, and sulfamethazine at median concentrations of 12, 44, 
and 3.2 ng/L, respectively. Forrest et al., (2011) also found monensin, sulfamethazine, and salinomycin in 
water samples from twenty-three small watersheds that are impacted by agriculture runoff (< 1000 km
2
) in 
the province of Alberta.  
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1.4 Regulations on Antimicrobial Use and Distribution 
Strategies for curbing the spread and emergence of resistant pathogens vary considerably worldwide. 
Several countries such as Norway, Sweden, and Denmark have imposed complete or partial bans on 
antimicrobial growth promoters.  Others have explored alternatives to antimicrobials such as natural 
growth promoters, probiotics, and in-feed enzymes (Hughes and Heritage, 2004). In 2011, the World 
Health Organization declared AMR as one of the top three threats to human health and urged countries to 
reduce antimicrobial use in veterinary practices and in human medication (WHO, 2011).  
 
The 1969 Swann Report from the United Kingdom is one of the landmark comprehensive studies linking 
antimicrobials use and antimicrobials resistance in bacteria (Guardabassi et al., 2008). In the decades 
following the release of the Swann Report, European countries started the gradual removal of 
antimicrobial growth promoters in livestock feeds, beginning with tetracycline, penicillin, and 
streptomycin. Sweden first banned growth promoters in agriculture in 1986. Then Norway, Denmark, 
Germany, the United Kingdom, and other European countries began progressively imposing restrictions or 
bans on several antimicrobials for veterinary use. In 2006, a complete ban on antimicrobial growth 
promoters was enacted in the entire European Union (European Commission, 2003). 
 
In the US, a wide range of antimicrobials, including several compounds that are considered important to 
human medicine (e.g., tetracylines and macrolides), are still permitted in veterinary practice as growth 
promoters. The US currently has the highest recorded domestic sales of veterinary antimicrobials for 
multiple years at approximately 13,700 tonnes per year (Table 1-1). It is estimated that growth promotion 
accounts for roughly 3 – 25 million pounds (1400 kg - 11, 300 kg) or approximately between 13% - 70% 
of the annual veterinary antimicrobial use in the country (Graham et al., 2007). More recently, the United 
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States Food and Drug Administration (FDA) expressed support for banning the use of antimicrobial 
growth promoters and restricting access to veterinary antimicrobials from over-the-counter access to 
prescription-only access (US FDA, 2012b). However, the removal of antimicrobial drugs in livestock feeds 
remains voluntary rather than mandatory (US FDA, 2013).   
 
A few Asian countries have also enacted legislation for regulating the consumption of growth promoters in 
the livestock industry. The use of growth promoters in animal farms has been banned in Korea since 2012 
(Kim et al., 2011). In Vietnam, a group of antimicrobial growth promoters, including chloramphenicol, is 
banned in agriculture (Kroismayr, 2007). In China, human health care policies have been amended in 
favour of prudent antimicrobial use but the country’s Ministry of Agriculture has not imposed similar 
tighter restrictions for veterinary antimicrobials (Xiao et al., 2013). In the Philippines, therapeutic 
antimicrobials are permitted but many known antimicrobials used for growth promotion have therapeutic 
indications. 
 
In Canada, Health Canada’s Veterinary Drug Directorate has recently announced a three-year phase out 
plan for growth promoters and medically-important antimicrobials in the livestock industry (VDD, 2014). 
It has also imposed tighter oversight regulations over the use of veterinary antimicrobials. Prior to this 
development, approximately 90% of Canada’s swine industry used antimicrobials (Kroismayr, 2007). The 
manufacture and sale of antimicrobials within the country is regulated through several federal legislations 
including the 1985 Food and Drugs Act (amended in June 2013), the 1985 Feeds Act (amended in June 
2006), and the 1990 Health of Animals Act (amended in January 2013). The access to and use of 
antimicrobials are also regulated at the provincial level, with most provinces allowing over-the-counter 
(OTC) access to veterinary antimicrobials. Québec and more recently, Newfoundland and Labrador, are 
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the only provinces that restrict access to veterinary antimicrobials to prescription-only access. Current 
provincial legislation is not focused on controlling AMR but rather on limiting drug residues in food 
producing animals (Prescott et al., 2012).  
 
Gaps in federal and provincial legislations give rise to two major loopholes in regulating the use and 
importation of antimicrobials in livestock production (Prescott and Szkotnicki, 2012).  These loopholes are 
referred to as the own use importation (OUI) loophole and active pharmaceutical ingredients (API) 
loophole. In the OUI loophole, any Canadian can import up to a three-month supply of permitted drugs as 
long as they will be used solely for individual purposes and not sold commercially. This provision in 
legislation was originally intended to allow importation of drugs for human medication but it does not 
prohibit livestock producers from importing antimicrobials for use in herds (Prescott and Szkotnicki, 
2012). Recently, the Ontario Medical Association advocated for tighter government control over cross-
border importation of cheaper antimicrobials from the United States (OMA, 2013). The API loophole 
originates from the gap between the provincial and federal regulations on the use and sale of veterinary 
medicine. The provincial government regulates antimicrobial use and the federal government controls the 
sales of antimicrobials. Through this loophole, veterinarians and pharmacists can import bulk chemicals 
that are considered active pharmaceutical ingredients. Once in Canada, these chemicals can be mixed with 
other compounds for eventual use in medication, without oversight by Health Canada.  
 
It is estimated that the OUI and API loopholes result in approximately $120 million annual loss in 
opportunity costs for the Canadian Government or the equivalent of 25% of current revenues from the sale 
of licensed veterinary drugs in Canada. Some of the suggested strategies to counter these loopholes include 
imposing bans on extra-label use of domestic and imported drugs and developing a new regulatory 
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framework for controlling the use of veterinary drugs based on their potential risk to the food supply and 
the end consumer. (Prescott and Szkotnicki, 2012)  
 
1.5 Epilogue  
This chapter underscores the increasing concern over the potential health threats associated with the 
extensive use of antimicrobials, the widespread environmental occurrence of residual antimicrobials, and 
the difficulties in regulating their global use. The emergence of resistant pathogens is a serious public 
health risk. Thus it is necessary to understand the eventual attenuation of antimicrobials in the 
environment.   
 
For policymakers and water regulators, a thorough risk analysis is the first step in quantifying these health 
risks. However, given the persistence of antimicrobials and the limited data on their use, a more 
comprehensive understanding of their occurrence and fate in the environment is necessary to initiate risk 
assessment. Such large-scale studies are costly and time-consuming; they can also be challenging given the 
unregulated consumption of veterinary antimicrobials in many countries (Isaacson and Torrence, 2002). 
There are also some logistical challenges associated with the timing and scale of environmental sampling, 
which often requires skilled personnel and training in advanced instrumentation (Zhang, 2007). The timing 
of sample collection is crucial when monitoring environmental contaminants. Variables such as manure 
spreading practices and climatic variability need to be considered when designing sampling protocols and 
frequencies. The use of computational tools (e.g., models) can help simplify field sampling and reduce the 
over-all costs of risk analysis. For example, robust load estimation models can be utilized as a powerful 
screening tool for identifying priority compounds and locations that are vulnerable to residual 
antimicrobials. Identifying the sources, consumption trends, and residual loads of antimicrobials is critical 
 17 
 
in mass transport modeling, which can be an integral part of risk analysis. Establishing consumption rates 
will also benefit efforts in assessing the health risks associated with the widespread use and occurrence of 
antimicrobials. 
1.6 Research Objectives 
The goal of the current research is to provide preliminary data on the occurrence and distribution of select 
antimicrobials in the environment through modeling and empirical data collection. The findings of this 
study can provide policymakers valuable insights on the consumption, sources, and environmental 
occurrence of relevant antimicrobials, and help identify strategies for mitigating their discharge and spread 
in the environment. The research results (model estimates and field data on antimicrobial concentrations) 
are also useful to other researchers who are interested in AMR risk assessment.   
The specific objectives of the current research are as follows: 
Objective 1: Develop a mass loading estimation model for veterinary antimicrobials to estimate 
their residual concentrations in a watershed; and  
Objective 2: Examine the distribution of select antimicrobials in a mixed-use watershed. 
The study area for this research is the Grand River Watershed (GRW), a mixed-use watershed in southern 
Ontario, Canada. Further description of the GRW can be found in Chapters 2 and 3. The rest of the 
research manuscript is organized as follows: Chapter 2 discusses the development and application of a 
mass load model for estimating the concentration of select antimicrobials in the GRW (Objective 1). 
Chapter 3 presents an analysis of the field data on antimicrobials that were collected from the GRW 
(Objective 2). Finally, Chapter 4 summarizes the findings and conclusions of this study, and identifies 
directions for future related work. 
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Chapter 2: Estimating Mass Loads of Veterinary Antimicrobials in 
Watersheds  
This chapter discusses the development and application of a mass load model for estimating the 
concentrations of residual veterinary antimicrobials in the environment. The results of this chapter can 
provide critical information in the assessment of the potential risks associated with the high use of 
antimicrobials in the livestock industry, their disposal, and eventual environmental fate. The chapter is 
organized into four sections, namely: (i) introduction, (ii) development and validation of a mass load 
estimation model, (iii) case study, and (iv) conclusions and future work. 
2.1 Introduction 
The potential to induce bacterial resistance is the most serious health threat associated with the high use of 
antimicrobials worldwide. Estimates of global consumption indicate that on average, 50% of 
antimicrobials are used in agriculture (Hughes and Heritage, 2004). Other data suggests significantly 
higher consumption in countries with higher meat production, for example, it is estimated that 80% and 
90% of the antimicrobials sold in the United States and Canada, respectively, are used in livestock (Palmer 
et al., 2011; CIPARS, 2011a). The high use of antimicrobials has been associated with the development of 
resistant genes in bacteria (Marshall and Levy, 2011). Similarities in resistance genes can give rise to 
resistance to multiple antimicrobials within the same class (cross-resistance). Resistance to a structural 
component of the antimicrobial can give rise to resistance in antimicrobials of other classes (co-resistance). 
Some bacterial resistance to human antimicrobials has been linked to the use of veterinary antimicrobials, 
for example, the veterinary use of avoparcin has been associated with the co-resistance of Enterococcus 
faecium to vancomycin, an antimicrobial used to treat serious infections in humans (Guardabassi and 
Kruse, 2008).  
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The frequent use of antimicrobials in livestock has also been linked to the widespread occurrence of low-
level antimicrobials in the environment, which may induce resistant genes in pathogens and eventually 
intensify disease burdens in humans (Andersson and Hughes, 2012). Mitigating this health risk requires a 
comprehensive evaluation of the entry points for residual antimicrobials in various environmental 
matrices, an assessment of their eventual fate and toxicity, and a thorough understanding of the 
transmission pathways for resistant genes. However, such large-scale reconnaissance studies are resource-
intensive and challenging to implement. Further, the difficulties in detecting low-level antimicrobials can 
be compounded by the temporal and spatial variabilities among regions (e.g., climatic conditions and 
varying farming practices). Despite these issues, it is widely recognized that the environmental prevalence 
of antimicrobials and resistant pathogens must be monitored to quantify their potential adverse impacts 
(Kümmerer, 2004).  
 
A risk assessment is normally the first step in quantifying the environmental and health risks associated 
with emerging contaminants such as antimicrobials. This process involves identifying contaminant 
sources, estimating residual concentrations, and determining toxicity levels. The results of a preliminary 
risk assessment help regulators identify priority areas for further evaluation, and formulate strategies for 
mitigation. The assessment is usually carried out with the aid of simple models (e.g., mass load and 
transport models) and assumptions that enable the rapid quantification of the severity of the perceived risks 
(e.g., toxicity levels). With antimicrobials, one of the major challenges in risk assessment is the lack of 
available data on consumption and administration (see Chapter 1). A simple mass load model can be 
developed to address this issue by optimizing the use of limited data and inferring needed information 
from other surrogate data (e.g., livestock production). This model can be used to quantify residual 
concentrations, which in turn determine toxicity and exposure risks in indicator organisms.   
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In the present study, a simple mass load model has been developed to perform a rapid estimation of the 
levels of residual veterinary antimicrobials in soil and water matrices. The model was validated using data 
from previous studies and was applied to a case study of the Grand River Watershed in Southern Ontario, 
Canada. The environmental concentrations of four priority veterinary antimicrobials, namely, 
sulfamethazine, lincomycin, monensin, and oxytetracycline were estimated for each sub-catchment of the 
watershed.  
2.2 Mass Loading Estimation Model Description 
2.2.1 Predicted Concentrations in Soil and Water 
The proposed mass load estimation model, shown in Equation 1, is based on the principles of mass 
balance.  It integrates antimicrobial administration practices, livestock statistics, and the physical-chemical 
characteristics of antimicrobials to estimate residual concentrations in soil, which in turn is used to 
estimate residual levels in water matrices. The model is developed for the soil matrix on the premise that 
the most common entry point for veterinary antimicrobials in the environment is via land application of 
contaminated manure. With minor modification, the model can also be used to estimate the concentration 
of antimicrobials in manure.  
PECs = (
D x T x B x L x Fℎ x  𝐹𝑒 
 ρ𝑠 x d
𝑥 
𝐴𝑝
𝐴𝑓
) C    Equation 1 
In Equation 1, PECs is the predicted antimicrobial concentration in soil amended with livestock manure 
(μg/kg), D is the daily dose of the antimicrobial administered to an animal (μg/kg/day), T is the duration of 
antimicrobial treatment (day), B is the average animal body weight (kg/animal), L is the livestock density 
in the pens (animal/ha), Fh is the fraction of the herd receiving antimicrobials treatment  (value between 0 
and 1), Fe is the fraction of the antimicrobial intake that is excreted in manure (value between 0 and 1), 𝝆s 
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is the soil bulk density (kg/m
3
),  d is the depth of manure penetration into soil (m), Ap is the area occupied 
by the pens (ha), Af is the area where manure is applied (ha), and C is the units conversion factor.  
The proposed model assumes that the livestock manure produced during the feeding period is entirely 
applied to land. A fraction multiplier can be easily introduced in Equation 1 if but a portion of this manure 
is instead used. Further, the model does not incorporate a spreading limit for manure, which is imposed in 
the European region to regulate nutrient inputs to farm soils. In Canada where the case application of the 
proposed model was performed (discussed in Section 2.3) an “individualized farm management plan” is 
enforced instead of a nutrient spreading limit (Robinson, 2006). In this plan, the amount of allowable 
manure that may be spread on a farm is predetermined from the characteristics of the underlying soil. For 
the case study, it is assumed that livestock manure is applied in the immediate vicinity of the livestock 
farm, either on the farmer’s own lot or on adjacent lots. This assumption is made based on a Canadian 
study indicating that in practice, 15 km is the maximum distance at which it is economically sustainable to 
transport livestock manure for subsequent land application as fertilizer (Freeze and Sommerfeldt, 1985).  
Lastly, the proposed model assumes negligible decomposition of the antimicrobials in manure before its 
amendment to soil. This assumption is conservative and can be easily modified to account for degradation 
during manure storage or treatment (e.g., composting). The rates of degradation for many antimicrobials 
during manure storage have reported to follow first order kinetics (Žižek et al., 2011; Wang and Yates, 
2008; Schlüsener et al., 2006). These rates are influenced by many factors including the chemical 
properties of the antimicrobial, manure composition, and storage conditions (Kim et al., 2011; 
Ramaswamy et al., 2010). 
 
The predicted antimicrobial concentrations in groundwater and surface water are calculated using 
Equations 2 and 3, respectively. These equations are recommended in the EU 93/67/EEC guidelines (EU 
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TGD 1998) and are used in this study without modifications. They are based on the partitioning behavior 
of contaminants at the soil-water interface under steady state conditions. Further, the equations assume 
negligible mass loss due to plant uptake or other biochemical transformations (e.g., photolysis).  
𝑃𝐸𝐶𝐺𝑊 =  
𝑃𝐸𝐶𝑠,20 𝑥 𝜌𝑠 
𝐾𝑠𝑤 𝑥 1000
     Equation 2 
𝑃𝐸𝐶𝑆𝑊 = (
𝑃𝐸𝐶𝑠  𝑥 𝜌𝑠
𝐾𝑠𝑤 𝑥 1000
3
)                Equation 3 
In Equation 2, PECGW is the predicted antimicrobial groundwater concentration (μg/L), PECs,20 is the 
antimicrobial soil concentration at a manure mixing depth of 20 cm (μg/kg), and KSW is the soil-water 
partitioning coefficient (μg/kg/ μg/L). In Equation 3, PECSW is the predicted antimicrobial surface water 
concentration (μg/L). This equation assumes that the antimicrobial in the manure partitions into pore water 
before it gets diluted threefold when it reaches the surface (EMEA 2008).  
2.2.2 Model Validation 
The proposed mass load estimation model in Equation 1 was validated using literature data for 
sulfamethazine and oxytetracycline consumption in swine and in cattle (Wang et al., 2014; Zhou et al., 
2013). The predicted and measured concentrations are summarized in Table 2-1. In all cases, the predicted 
concentrations are higher than the measured concentrations, within the same order of magnitude and up to 
an order of magnitude higher. For comparison, predicted soil concentrations were also calculated using the 
EU Directive’s CVMP equation (EMEA, 2008). Predictions from the daily normalized CVMP equation 
are higher than the measured antimicrobial concentrations by up to two orders of magnitude, and generally 
by an order of magnitude higher than the results from the proposed estimation model.   
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Table 2-1: Measured and Predicted Soil Concentrations 
  
 
 
  
 
Antimicrobial Livestock Type MECsoil PECsoil Δ D T B L Fh Fe d SL Ny
Sulfamethazine Swine 18.9 ± 6.4
a
26.38
a
7.5 11.5 1 106 25000 1 1 1150 0.1 1 1
3.69 ± 0.42
b
11.1
b
7.4 10 29 106 500 1 1 1400 0.1 1 1
18.9 ± 6.4
a
527.7
c
508.8 11.45 1 106 25000 1 - 1150 0.1 150 0.021
1
Oxytetracycline Swine 36.8 ± 3.2
a
109
a
72.3 47.4 1 106 25000 1 1 1150 0.1 1 1
36.8 ± 3.2
a
35
c
2.1 47.4 1 106 25000 1 - 1150 0.1 150 0.021
Cattle 34.9 ± 1.0
a
68.9
a
34.0 307 3 200 430 1 1 1150 0.1 1 1
34.9 ± 1.0
a
9.32
c
25.58 307 3 200 430 1 - 1150 0.1 150 0.049
a) Wang et al., 2014
c) CVMP Converted Daily
b) Zhou et al., 2013
Prediction and Difference Proposed Model Variables CVMP Model VariablesLiterature-Reported Information
Proposed Model Variables: D: Dose; T: Treatment Days; B: Body Weight; L: Livestock Density; Fh: Fraction Herd Treated; Fe: Fraction Excreted;      : Soil Density; d: Depth of 
Soil; SL: Spreading Limit; Ny: Yearly Nitrogen Production
 s
s
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2.2.3 Sensitivity Analysis 
A nominal range sensitivity analysis was performed to examine the sensitivity of the model predictions to 
the variables in the proposed mass load model in Equation 1. The analysis was carried out for the 
hypothetical scenario of swine livestock in Ontario, Canada receiving sulfamethazine in feedstuff. A base 
value for the predicted soil concentration, designated as PECS
0
, was calculated using nominal values of the 
variables listed in Table 2-2, and considering a ratio of 1 for Ap:Af (shed size same as farm lot size).  The 
nominal values of the variables were the midpoint of their ranges. For each variable, the range of PECS 
values were calculated using the variable’s high (x+) and low (x-) values that were either obtained or 
calculated from literature, and while keeping all other variables at their nominal values. For the 
sulfamethazine daily dose (D), the high and low values were calculated from CFIA (2014) and Wang et al. 
(2014). For the duration of treatment (T), the range was from the duration for stress therapy (10 days, 
CFIA, 2014) to rhinitis treatment (42 days, Bāckström et al., 1994).  For the livestock body weight (B), the 
low value was the weight of a starter swine (12.5 kg) and the high value was the weight of a grower (65 
kg) (CFIA, 2014). The livestock density was calculated as the number of swine divided by the available 
arable land in a region. Arable land includes land for crops, summer fallow, tame/seeded pasture and 
natural pastureland. The livestock densities for the Ottawa Division and Huron County were assigned as 
the low and high values (OMAFRA, 2011). For Fh (fraction of herd treated), a conservative value of 1.0 
was assigned as the high value and 0.1 as the low value (for rhinitis treatment, Bāckström et al., 1994). The 
nominal value for Fe (excreted fraction of sulfamethazine intake) was the average of a conservative 
estimate (1.0) and 0.52 (Paulson et al., 1981). The soil bulk density (𝝆s) ranged from 900 kg m
-3
 to 1600 kg 
m
-3
 (British Columbia Ministry of Agriculture and Food, 1990). The manure incorporation depth in soil (d) 
ranged from 0.05 m to 0.2m (EMEA, 2008).   
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Table 2-2: Nominal, High, and Low Values Used in Sensitivity Analysis 
 
 
 
  
 
Variable Units Nominal ( x
0 
)
a
High ( x
+ 
) Low ( x
- 
) Reference
Dose
b  
(D) μg/kg/day 192500 275000 110000 CFIA, 2014; Wang et al., 2014a
Treatment Duration (T) day 26 42 10 CFIA, 2014; Bāckström et al., 1994 
Body Weight (B) kg/animal 38.75 65 12.5 CFIA, 2014
Livestock Density
c
 (L) animal/ha 1.07 2.1 0.043 OMAFRA, 2011
Fraction Treated (Fh) Value from 0-1 0.55 1 0.1 Bāckström et al., 1994 
Fraction Excreted (Fe) Value from 0-1 0.76 1 0.52 Paulson et al., 1981
Soil Bulk Density kg/m
3
1250 1600 900 British Columbia Ministry of Agriculture and Food, 1990
Depth (d) m 0.15 0.2 0.1 EMEA, 2008
a) The nominal value was taken to be the mean of the high and low x values.
b) Dose was calculated by multiplying dose (110mg and 44mg) by feed intake per day (2.5 kg).
c) Livestock density was found by dividing swine within county by arable land)
(Arable land is the summation of land for crops, summer fallow, tame/seeded pasture, and natural  pastureland)
(𝝆s)
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Figure 2-1 shows the effect of the variables on the predicted sulfamethazine soil concentration. For the 
range of variable values considered in Table 2-2, the livestock density (L) has the highest effect on the 
model predictions (nearly twice of PECS
0
) while the soil density () has the least effect (28% of PECS
0
), 
followed by the fraction of sulfamethazine excreted (Fe, 32% of PECS
0
). This trend is largely due to the 
wide range of the L values, which vary by two orders of magnitude (10
-2
 to 10
0
). These results suggest that 
for this case illustration, more careful consideration should be made in estimating livestock densities 
compared to the other variables in Equation 1.   
 
Figure 2-1: Effect of Variables on the Predicted Sulfamethazine Soil Concentration, PECS. The 
Livestock Density (L) has the Highest Effect on PECS (96% of base PECS) While Soil Density (s) 
has the Least Effect (28% of base PECS). 
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2.3 Case Study  
2.3.1 Study Site 
The proposed mass load model in Equation 1 was applied to a case study of select veterinary 
antimicrobials in the Grand River Watershed in Ontario, Canada. The watershed drains an area of 6800 
km
2
 and is the largest watershed in southern Ontario (Figure 2-2). It comprises 11 sub-basins: Upper 
Grand, Upper Middle Grand, Middle Grand, Lower Middle Grand, Lower Grand, Conestogo, Fairchild 
Creek, McKenzie Creek, Nith, Speed, and Whiteman’s Creek. In addition to livestock production and crop 
farming, this mixed-use watershed supports manufacturing and commercial industries as well as urban 
development. Land is largely allocated to agriculture (75% is actively farmed) and intensive livestock 
production. In 2001, the watershed had an estimated 290,000 cattle, 500,000 swine, and 8.8 million poultry 
(GRCA, 2008). Livestock operations are heavily concentrated in the Upper Middle Grand, Conestogo, and 
Nith basins (Table 2-3). The majority of the population (985,000 in 2014) lives in the urban areas in the 
Middle Grand and Speed sub-basins (Chapman and Anderson, 2011; Farwell et al., 2008).  
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Figure 2-2: The Grand River (blue) and its 11 Sub-Basins (black): (1) Upper Grand, (2) Upper 
Middle Grand, (3) Middle Grand, (4) Lower Middle Grand, (5) Lower Grand, (6) Conestogo, (7) 
Fairchild Creek, (8) McKenzie Creek, (9) Nith, (10) Speed and (11) Whiteman’s Creek. 
Table 2-3: Livestock Density by Sub-basin (Livestock per Hectare) 
Sub-basin  Density of Cattle      Density of Swine  Density of Poultry 
Upper Grand 0.28 0.21 4.70 
Upper Middle Grand 0.55 0.80 19.6 
Middle Grand 0.56 0.63 16.6 
Lower Middle Grand 0.11 0.11 7.90 
Lower Grand 0.10 0.27 10.3 
Conestogo 0.55 0.83 20.2 
Fairchild Creek 0.17 0.14 9.30 
McKenzie Creek 0.06 0.12 5.20 
Nith  0.52 1.10 15.7 
Speed 0.49 0.78 18.9 
Whiteman’s Creek 0.32 0.93 11.8 
Sources: Livestock populations were calculated from data from OMAFRA (2011). 
Densities were calculated using averaging methods. Land area maps were 
provided by the University of Waterloo Geospatial Centre. 
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2.3.2 Data Inputs 
The mass load model in Equation 1 was used to estimate the residual soil concentration of four 
antimicrobials, namely, sulfamethazine, lincomycin, monensin, and oxytetracycline, from three groups of 
livestock: swine, cattle, and poultry. These livestock groups were chosen because of their high production 
in Canada (Statistics Canada, 2014). The target compounds belong to different classes of veterinary 
antimicrobials and are among the most widely used antimicrobials in livestock production. Sulfamethazine 
is a sulphonamide used in the treatment of bacterial enteritis, dysentery and pneumonia in swine and in 
growth promotion in cattle. Lincomycin is a lincosamide used to treat mastitis in dairy cows as well as 
diarrhea in young swine. Monensin, an ionophore, is administered as a growth promoter in cattle and as a 
coccidiostat in poultry. Lastly, oxytetracycline is from the tetracycline class and is used to treat stress, 
enteritis, rhinitis, respiratory diseases and bacterial diarrhea in cattle, poultry and swine. In Canada in 
2008, the combined sales of sulphonamides and trimethoprim amounted to 59 tonnes (for livestock use 
only). In the same year, 41 tonnes of lincomycin, 472 tonnes of ionophores, and 681 tonnes of 
tetracyclines were sold for veterinary use (CIPARS 2011a).  
For the model application, the data inputs for each target antimicrobial and livestock are listed in Table 2-
4.  These values were either obtained or calculated from literature data. The estimated livestock densities 
and manure production in the Grand River Watershed are shown in Figure 2-3.  
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Table 2-4: Variable Inputs for PECS Calculations for the Case Study 
 
2.3.3 Results and Discussion 
2.3.3.1 Basin-wide Pattern of Predicted Concentrations 
The predicted antimicrobial concentrations in soil and surface water are shown in Figures 2-4 and 2-5, 
respectively. Predicted soil concentrations range from 0.1 μg/kg (monensin and oxytetracycline) to 60 
μg/kg (sulfamethazine). In general, predicted monensin concentrations are the lowest among the model 
estimates for the four target compounds, and are about ten to a hundred times lower than the predicted 
sulfamethazine concentrations (Figure 2-6; Table 2-5). Estimates for antimicrobial concentrations in 
Antimicrobial Livestock Type D
a
T
a
B L
b
Fh Fe d
mg/kg day kg animal/ha 0-1 0-1 kg m
3
m
Lincomycin Swine 220 21 65 Table 2-3 0.42 0.21 1550 0.05
Cattle N/A N/A N/A N/A N/A N/A N/A N/A
Poultry N/A N/A N/A N/A N/A N/A N/A N/A
Monensin Swine N/A N/A N/A N/A N/A N/A N/A N/A
Cattle 0.000165 365 200 Table 2-3 0.76 0.95 1550 0.05
Poultry 0.0033 365 1 Table 2-3 1.0 0.94 1550 0.05
Oxytetracycline Swine 0.11 365 65 Table 2-3 0.15 1.0 1550 0.05
Cattle 0.375 365 200 Table 2-3 0.1 1.0 1550 0.05
Poultry 0.0038 365 1 Table 2-3 1.0 1.0 1550 0.05
Sulfamethazine Swine 110 365 12.5 Table 2-3 0.08 1.0 1550 0.05
Cattle 350 28 200 Table 2-3 0.05 0.3 1550 0.05
Poultry 0.0038 365 1 Table 2-3 1.0 1.0 1550 0.05
N/A indicates that antimicrobial is not used in that particular livestock.
Model Variables: D: Dose; T: Treatment Days; B: Body Weight; L: Livestock Density; Fh: Fraction Herd 
Treated; Fe: Fraction Excreted;      : Soil Density; d: Depth of Soil
a. Dosage and treatment day information come from Compendium of Medicating Ingredient Brochures 
(CFIA) Accessed May 22, 2014.
b. Livestock density (L) values are different for each sub-basin. Values for each sub-basin for which the 
model was calculated can be viewed in Table 2-3.
𝝆s
s
 31 
 
surface water range from the low ng/L to low μg/L levels. Model predictions for oxytetracycline, a 
compound that preferentially partitions to soil, are lower than monensin in surface water and ground water 
estimates and are generally four orders of magnitude lower than the predicted sulfamethazine 
concentrations.  
 
Across the watershed, the trends in the predicted mass loads of antimicrobials generally follow the trend in 
livestock population and manure densities in the sub-basins (Figure 2-3).  These trends indicate that the 
residual veterinary antimicrobials in the Grand River Watershed mostly come from the six sub-basins in 
the middle portion of the watershed. Estimated livestock densities and antimicrobial loads are highest in 
the Nith sub-basin, followed by the Whiteman’s Creek, Conestogo, and Upper Middle Grand sub-basins. 
The Nith sub-basin has the highest predicted soil concentrations for sulfamethazine, lincomycin, and 
oxytetracycline at 60 μg/kg, 38 μg/kg, and 1.4 μg/kg, respectively. The predicted surface water 
concentrations for sulfamethazine (18 μg/L) and lincomycin (10 μg/L) are also highest in this sub-basin. 
The highest surface water concentrations for monensin occur in the Conestogo (0.84 μg/L) and Upper 
Middle Grand sub-basins (0.83 μg/L). The maximum estimated oxytetracycline surface water 
concentration is about a thousand times lower than predicted lincomycin concentrations, with a peak value 
of only 0.4 ng/L in the Nith, Conestogo, Speed, Middle and Upper Middle Grand sub-basins (Table 2-5). 
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Figure 2-3: Estimated Density of Cattle, Swine, and Poultry Populations per Hectare as well as Total 
Estimated Manure Density in Tonnes per Hectare. 
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Figure 2-4: Predicted Soil Concentrations of Target Veterinary Antimicrobials in the Grand River 
Watershed 
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Figure 2-5: Predicted Surface Water Concentrations of Target Veterinary Antimicrobials in the 
Grand River Watershed. 
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Table 2-5: Predicted Environmental Concentrations of Target Antimicrobials in the Grand River 
Watershed 
 
 
The trends for the sulfamethazine, lincomycin and oxytetracycline concentrations follow the same pattern 
as the swine density map (i.e., highest concentration in the Nith). In contrast, monensin levels instead first 
peak in the Conestogo, Upper Middle, and Speed sub-basins, and then in the Nith sub-basin. This 
difference is attributed to the higher poultry densities in the first three basins.  In Canada, monensin is 
prescribed only for cattle and poultry.  Hence, despite the high swine density in the Nith sub-basin, swine 
manure has no contribution to the residual monensin load in the environment. In all environmental 
matrices (soil, surface water, groundwater), sulfamethazine has the highest predicted concentration, 
followed by lincomycin. In soil, the predicted oxytetracycline concentration is higher than the predicted 
monensin level; this trend is reversed in the water matrix where oxytetracycline has lower affinity.  
 
The estimated soil concentrations of the four target antimicrobials are plotted in Figure 2-6. The top six 
contributors of antimicrobials, in decreasing order, are: Nith, Whiteman’s Creek, Conestogo River, Upper 
Middle Grand, Speed River and Middle Grand. Individually, none of the target antimicrobials exceed the 
LIN MON OXY SMZ LIN MON OXY SMZ LIN MON OXY SMZ
NITH RIVER 37.7 0.4 1.4 60 9.9 0.7 4.1E-04 18 7.4 0.5 1.8E-04 14
WHITEMANS CREEK 31.9 0.2 0.8 50 8.4 0.4 2.3E-04 15 6.3 0.3 1.4E-04 12
CONESTOGO RIVER 28.5 0.5 1.4 46 7.5 0.8 4.1E-04 14 5.6 0.6 1.5E-04 11
UPPER MIDDLE GRAND 27.4 0.5 1.4 44 7.2 0.8 4.1E-04 14 5.4 0.6 1.5E-04 10
SPEED RIVER 26.5 0.4 1.3 42 7 0.8 3.7E-04 13 5.2 0.6 1.4E-04 10
MIDDLE GRAND 21.3 0.4 1.4 35 5.6 0.8 4.1E-04 11 4.2 0.6 1.3E-04 8.2
LOWER GRAND 9.3 0.2 0.3 15 2.5 0.3 7.2E-05 4.5 1.8 0.2 4.4E-05 3.5
UPPER GRAND 7.3 0.1 0.6 12 1.9 0.3 1.7E-04 3.8 1.4 0.2 5.4E-05 2.9
FAIRCHILD CREEK 5 0.2 0.3 8.3 1.3 0.3 9.2E-05 2.6 1.0 0.2 3.6E-05 2.0
MCKENZIE CREEK 4.3 0.1 0.1 6.7 1.1 0.1 3.7E-05 2.1 0.8 0.1 2.1E-05 1.6
LOWER MIDDLE GRAND 3.6 0.1 0.2 6 1.1 0.2 5.2E-05 1.9 0.7 0.2 2.5E-05 1.4
Sub-basin
PECS (μg/kg) PECGW (μg/L)PECSW (μg/L)
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recommended 100 μg/kg threshold for a Phase II toxicity risk assessment (EMEA 2008). However, the 
sum of the predicted antimicrobial concentrations in the Nith sub-basin is very close to this threshold 
value. Although the individual toxicities of antimicrobials have been reported for several indicator species, 
there are very few studies that have examined the synergistic or antagonistic effects of drug mixtures. Such 
studies are especially critical in studying the collective effects of antimicrobials on the development of 
resistant genes in bacteria (Vasquez et al., 2014). 
 
Figure 2-6: Estimated Soil Concentrations of Target Antimicrobials by Sub-basin 
2.3.3.2 Correlations between Drugs, Animals, and Manure 
Given the limited availability of accessible data on the consumption of veterinary antimicrobials (see 
Chapter I), manure production may be conveniently used as a surrogate indicator of the levels of 
antimicrobials in the terrestrial environment. To evaluate the validity of this approach, a multivariate 
correlation analysis was performed for the following parameters: target antimicrobial, livestock type, and 
 37 
 
manure density. The analysis was performed using the Data Analysis toolkit in Microsoft Excel
®
. Of the 
four antimicrobials, three correlate well with swine density: sulfamethazine (R
2
 = 0.96), lincomycin (R
2
 = 
0.99), and oxytetracycline (R
2
 = 0.99). Monensin is most correlated with poultry density (R
2
 = 0.99) while 
sulfamethazine is the only antimicrobial correlated with cattle density (R
2
 = 0.96). Overall, manure density 
is well correlated with all of the four antimicrobials: sulfamethazine (R
2
 = 0.99), oxytetracycline (R
2
 = 
0.94), lincomycin (R
2
 = 0.92), and monensin (R
2
 = 0.89). The order of these correlations reflects the 
impacts of the livestock size (or weight) on the antimicrobial mass load prediction. Swine and cattle 
produce significantly higher amounts of manure than poultry. Therefore, antimicrobials administered to 
larger animals may correlate better with manure production than those administered to smaller animals that 
excrete less manure. The results of the correlations suggest that the livestock type, livestock density, and 
the antimicrobial dosage are important in estimating the environmental concentrations of veterinary 
antimicrobials on a large scale. Results also suggest that manure production can be used to indicate the 
presence of certain but not all antimicrobials. For example, if there is a significant amount of manure from 
poultry, it is likely that monensin is present but not necessarily lincomycin.    
2.4 Conclusions and Future Work  
This chapter demonstrates the versatility of a simple mass load model in estimating the residual levels of 
veterinary antimicrobials in soil and water. The model requires only a few parameters, making it 
convenient to use especially when accessible data are limited. The case application for the Grand River 
Watershed suggests that residual concentrations of the studied antimicrobials do not exceed recommended 
threshold values for further toxicity risk assessment. The results from the case study could help risk 
assessors prioritize sub-basins and target compounds for further studies.  The proposed estimation model 
can be used in conjunction with other contaminant transport models to study the attenuation of veterinary 
antimicrobials in small sub-basins or catchments.  It can also be employed as a screening tool for assessing 
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the risks associated with the widespread use of antimicrobials that are used for therapeutic and non-
therapeutic applications in farms. Results from the model simulations can be used to quantify the health 
risks associated with the discharge of residual veterinary antimicrobials to the environment.  
Future work on the proposed mass load model can focus on incorporating the effects of in-soil 
degradation, farm practices such as manure storage and composting, and manure application methods. The 
residual environmental concentrations may also be estimated based on mass transport rather than on static 
mass balance methods alone. However, this approach may become too complex and tedious as data 
requirements expand rapidly. The advantage of a mass transport-based model is its ability to integrate 
farming practices (e.g. tilling), farm features (e.g., buffer strips), and other environmental processes (e.g., 
sediment transport, non-linear sorption) into the prediction calculations. It is therefore the task of the 
model user to find a balance between the complexity of using the model and the reliability of the model 
predictions. The proposed mass load model achieves this balance through its relatively minimal data 
requirements and its demonstrated accuracy in predicting the residual concentrations of priority 
antimicrobials. 
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Chapter 3: Occurrence and Distribution of Select Antimicrobials in the 
Grand River Watershed, Canada  
This chapter discusses the findings of a field survey sampling conducted in the Grand River Watershed in 
Ontario, Canada in Fall 2013. It comprises five sections, namely: literature review, methodology, results, 
discussion, and summary. The chapter will be submitted as a research manuscript nearly in its entirety to 
Water Research, with co-authors SA Pagsuyoin (research supervision and manuscript review), L Bragg 
(development of method for chemical chromatographic analysis and supervision of laboratory analysis), 
and M Servos (research guidance and manuscript review).  
3.1 Literature Review 
The persistence of antimicrobials in the environment is a rising global concern due to its close link to 
antimicrobial resistance (AMR). Globally, antimicrobials, including medically important antibiotics, have 
been detected in various environmental media at concentrations ranging from parts per trillion to parts per 
billion (Kolpin et al., 2002). The majority of these measured values are below the 1 μg/L threshold 
recommended for a Phase II risk assessment by the Committee for Medicinal Products for Veterinary Use 
(CVMP) of the European Union. However, more studies are still needed to establish synergistic and 
chronic exposure effects in aquatic and terrestrial organisms (Kemper, 2008; Flaherty and Dodson, 2005).  
Available literature on the environmental occurrence of antimicrobials mostly focuses on wastewater 
effluents and antimicrobials for human medication. For example, Guerra et al. (2014) examined the 
removal efficiencies of pharmaceuticals in six wastewater treatment plants and found that antimicrobials 
(antibiotics and antifungals) were more likely to sorb to biosolids. Miao et al. (2004) detected several 
human antimicrobials in treated effluents but only at concentrations below 1 μg/L.  Human antimicrobials 
have also been detected in streams that receive wastewater effluents; for instance, medically important 
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antimicrobials (e.g., tetracycline, trimethoprim, erythromycin) have been detected in rivers in North 
America (Forrest et al., 2011; Waiser et al., 2011; Verma et al., 2007; Kolpin et al., 2002).  
In general, watershed-scale studies on the transport of antimicrobials are limited compared to similar 
studies for traditional pollutants such as nitrogen and phosphorus (Iglesias et al., 2014). The attenuation of 
a few antimicrobials (e.g., triclosan, triclocarban) in effluent-receiving streams has been studied (Arlos et 
al., 2014; Gautam et al., 2014; Singer et al., 2002). The transport of veterinary antimicrobials in small 
farms, shallow streams, and small watersheds has also been evaluated (Joy et al., 2013; Forrest et al., 2011; 
Lissemore et al., 2006). Recent research findings have highlighted the need to further examine the 
environmental occurrence of antimicrobials as well as the impact of runoff and effluent discharge on 
inducing AMR in organisms (Finley et al., 2013a; Kümmerer, 2009; Kemper, 2008). In Canada, despite 
the presence of large agricultural areas with high livestock production, there has not been any large-scale 
reconnaissance survey of antimicrobials in surface waters similar to that done by Kolpin et al. (2002) in the 
United States. 
 
The widespread consumption and the environmental persistence of antimicrobials, along with the potential 
for inducing resistance traits in organisms, necessitate a more comprehensive understanding of 
antimicrobials fate and transport in the environment. With this in mind, the primary goal of the current 
study is to examine the patterns of occurrence of priority antimicrobials in a mixed-use watershed. 
Previous researchers have also underscored the need to identify the sources of residual antimicrobials in 
the environment to formulate appropriate strategies for managing health risks associated with AMR in 
pathogens (Finley et al., 2013a; Kümmerer, 2009). Thus, the second goal of this study is to provide 
insights on the point and non-point origin of frequently detected antimicrobials. Five priority 
antimicrobials from three classes were selected on the basis of their consumption in human and animal 
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medication: sulfamethazine, sulfamethoxazole, trimethoprim, lincomycin, and monensin (Table 3-1). 
Sulfamethazine and sulfamethoxazole belong to the sulphonamide class of antimicrobials. Sulphonamides 
competitively inhibit an enzyme (dihydropteroate synthetase) in microorganisms by reducing the uptake of 
p-aminobenzoic acid needed for dihydrofolic acid synthesis (Talwar and Srivastava, 2006; Grande et al., 
2001). They are the second most prescribed antimicrobials worldwide (Kim et al., 2011) and are one of the 
top five most prescribed antimicrobials in Canada (CIPARS, 2012b). Sulfamethazine is one of the most 
commonly used veterinary antimicrobials from the sulphonamide class, while sulfamethoxazole is a 
human antimicrobial used to treat urinary tract infections, bronchitis, and sinusitis. Trimethoprim, a 
diaminopyrimidine, is prescribed for the treatment of infections of the respiratory and urinary tract in 
humans. Lincomycin is a type of lincosamide that is used to treat bacterial infections that cause dysentery, 
pneumonia and proliferative enteritis in swine (CFIA, 2014). Monensin, a member of the ionophore class, 
targets protozoa and bacteria. It is mainly used as a coccidiostat in poultry and as a growth promoter in 
cattle. It is also administered in low doses to increase feed efficiency in lactating dairy cattle (CFIA, 2011). 
Three chemicals, namely, ibuprofen, venlafaxine, and atrazine, were also included in the analyte list to 
indicate point and non-point sources. Ibuprofen and venlafaxine are used in human medication; ibuprofen 
is an anti-inflammatory drug while venlafaxine is an antidepressant. Atrazine is an herbicide used in the 
control of weeds and pests in crop farms, residential lawns, and golf courses (Sherchan and Bachoon, 
2011). 
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Table 3-1: Properties of the Target Antimicrobials 
Antimicrobial Molecular 
Weight  
Water 
Solubility 
(mg/L) 
pKa 
 
log Kow Structure 
Sulfamethazine 278.3
 
1500
1 2.07, 
7.6
2 0.19
1 
 
Sulfamethoxazole 253.3
 
370
3 1.85, 
5.6
2 0.89
4 
 
Trimethoprim 290.3 400
1 
7.1
1 
0.91
1 
 
Lincomycin 406.5
 
927
5
 7.64
6 
-0.25
6, 
 
Monensin 670.9
 
0.003
1 
6.6
1 
5.43
1 
 
1)   Iglesias et al., 2014    2)   Yu et al., 2011 (pKa 1 and pKa 2 respectively)    3)   Tolls, 2001 
4)   Yargeau et al., 2007   5)    Subedi et al., 2014    6)   Kuchta et al., 2009  
 
3.2  Methodology 
3.2.1 Study Site 
The study area is the Grand River Watershed (Figure 3-1), the largest watershed in Southern Ontario, 
Canada that drains an area of 6800 km
2
.  It is divided into 11 sub-basins: (1) Upper Grand, (2) Upper 
Middle Grand, (3) Middle Grand, (4) Lower Middle Grand, (5) Lower Grand, (6) Conestogo, (7) Fairchild 
Creek, (8) Mckenzie Creek, (9) Nith, (10) Speed and (11) Whiteman’s Creek. Urban centres are 
concentrated in the Middle Grand and Speed basins. Livestock operations are heavily concentrated in the 
Upper Grand, Conestogo, and Nith basins. The watershed’s river network consists of a 300-km main 
channel and three primary tributaries. Ninety-three percent of the land in the watershed is considered rural 
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(farmlands and forest). The watershed supports manufacturing and commercial industries, as well as 
intensive agriculture. It has approximately 6000 farms with a collective annual production of 290,000 
cattle, 500,000 hogs, and 8.8 million poultry in addition to various crops (Farwell et al., 2008). There are 
also a total of 30 municipal wastewater treatment plants that serve a population of 985,000 (Chapman and 
Anderson, 2011). This population is projected to reach 1.4 million in 2031 partly due to the watershed’s 
proximity to the City of Toronto and the Golden Horseshoe region (Farwell et al., 2008).  
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Figure 3-1: Map of the Grand River Watershed and Sampling Locations. Gi labels indicate sampling 
sites in the main channel; CC1 indicates sampling site in the Canagagigue Creek in the Upper 
Middle Grand sub-basin; C1 indicates sampling site in Conestogo River; N1 indicates sampling site 
in the Nith River tributary; S1 indicates sampling site in the Speed tributary; W1 indicates sampling 
site in Whiteman’s Creek; and WWTPi labels indicate effluent sampling sites. 
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3.2.2 Sample Collection  
A total of 117 water samples were collected over a 2-day sampling event in early December 2013 from 32 
locations (27 from the main channel and 5 from incoming creeks or tributaries) along the Grand River 
Watersheds’ river network (surface water) and from 7 wastewater treatment plants (effluent) located within 
the watershed (5 from the main channel, 2 from the Speed River tributary) (Figure 3-2). Sampling sites 
were selected based on sub-basin characteristics (e.g., predominant land use) and on results from 
preliminary sampling efforts that indicated the presence of antimicrobials at these locations. Triplicate 
samples were taken at equidistant locations within each reach, one each from the left bank, right bank, and 
mid-channel. However, due to safety considerations, samples were taken only from one side of the river at 
three reaches (G10, 112 km downstream; G15, 133 km downstream; and G25, 176 km downstream). The 
river samples were collected in 500-mL amber glass bottles covered with Teflon®-lined screw caps and 
preserved on-site with 2.5 mL of 200 g/L sodium azide solution and 1.25 mL of 20 g/L ascorbic acid 
solution. The effluent samples were collected in 125-mL amber glass bottles and preserved similarly to the 
river samples. All bottles were filled to the brim to prevent analyte degradation, and kept in coolers 
maintained below 4°C until sample processing. Water temperature, pH, and conductivity were also 
measured onsite using a YSI ProfessionalPlus multimeter outfitted with a quarto-cable (YSI; Yellow 
Springs, OH). Additional water samples were collected in polyetheylene bottles for nutrient and chloride 
analyses (500 mL for nitrate, nitrite, total phosphorus and dissolved chloride analyses, and 250 mL for 
total ammonia).  These were analyzed by an external laboratory (Maxxam Analytics, Waterloo, Ontario).  
 
Temporal water sampling was also performed at four locations in the Nith River tributary and two in the 
Grand River (immediately above and below the confluence of the Nith and Grand Rivers). Sampling was 
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performed five times over an approximate two-week interval, from the end of September to early 
December 2013.  
3.2.1 Materials Preparation and Storage 
Chemical reagents, analyte standards (≥ 98% pure), and solvents (HPLC-grade) were purchased from 
Sigma Aldrich
®
 (Oakville, Ontario). Deuterated standards (atrazine-d5, ibuprofen-d3, sulfamethazine-d4, 
sulfamethoxazole-d4, trimethoprim-d3, and venlafaxine-d6 HCl) were purchased from CDN Isotopes Inc. 
(Pointe-Claire, Quebec). Stock solutions of the analytes were prepared in methanol and stored in 8-mL 
amber glass vials at -20C. Working solutions were prepared from these stock solutions just prior to 
chromatographic analyses. 
3.2.2 Sample Extraction and Analysis 
All samples were processed within 48 hours of collection. The raw water samples were filtered using a 0.3 
μm x 47 mm glass fiber filter (Type A/E, Pall Life Sciences) to remove suspended particulate matter.  
Filtrates were adjusted to pH 2 with 10 N HCl, spiked with 100 μL deuterated standards, and loaded onto 
preconditioned Bond Elute Plexa cartridges (500 mg / 6cc, Agilent Technologies) at the rate of 5 mL/min. 
Solid phase extraction was performed using Dionex AutoTrace 280 (Thermo-Fisher Scientific) or a 
vacuum manifold (Visiprep, Supelco). A separate test was performed to confirm that there was no 
statistical difference between the recovery rates using either extraction equipment. The cartridges were 
preconditioned with 5 mL methanol and equilibrated with 5 mL LCMS-grade water. The loaded cartridges 
were eluted with 6 mL methanol. Eluates were vacuum dried to dryness under a gentle stream of nitrogen, 
reconstituted with 500 μL methanol, transferred to 2-mL HPLC vials, and stored at -20°C until 
chromatographic analysis. 
Analyte concentrations were measured using an Agilent 1200 HPLC with an Applied Biosystems 3200 
QTRAP® mass spectrometer equipped with an electrospray ionization source and a triple quadropole 
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analyzer.  Analyte separation was achieved in an Agilent Eclipse
®
 C18 column (4.6 mm × 150 mm × 5.0 
μm). A mobile phase mixture of 5mM of ammonium acetate solution (A) and HPLC-grade methanol (B) 
was pumped through the column at a rate of 0.8 mL/min using a gradient program in both positive and 
negative modes held at 25 °C. Except for ibuprofen, all target compounds were detected in positive mode.  
Ibuprofen, along with other analytes not reported in this paper, was detected in negative mode. For the 
positive mode, the elution gradient was as follows: 0-0.5 min: 90% A, 0.5-8 min: 50→0% A, 8-10 min: 
0% A, 10-15 min: 90% A. For the negative mode, the elution gradient was as follows: 0-0.5 min: 90% A, 
0.5-8 min: 60→0% A, 8-10 min: 0% A, 10-15 min: 90% A. The sample injection volume was 20 μL and 
the block heater temperature was 25 ˚C. Nitrogen was used as the nebulizing and heating gas. Tracked 
precursor and product ions, as well as the collision energies for the analytes are listed in Table 3-2. 
Table 3-2: Compound Dependent LC-MS/MS Parameters 
Compound Precursor 
(m/z) 
Product 
(m/z) 
Collision Energy 
(Volts) 
Antimicrobials    
Sulfamethazine 279 92 41 
Sulfamethoxazole 254 156 22 
Trimethoprim 291 261 32 
Lincomycin
 
407 126 50 
Monensin 693 675 56 
Chemical Indicators    
Ibuprofen 205 161 -11 
Venlafaxine 278 58 42 
Atrazine 216 174 27 
Deuterated Compounds    
d-Sulfamethazine 283 96 43 
d-Sulfamethoxazole 260 121 37 
d-Trimethoprim 294 230 31 
d-Ibuprofen 208 164 -10 
d-Venlafaxine 284 64 35 
d-Atrazine 22 179 22 
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3.2.3 Quality Control and Quantitation 
All glassware were triple-rinsed in distilled de-ionized (DI) water and washed with methanol prior to use. 
The calibration curves for each analyte were constructed by preparing serial dilutions (0 to 500 μg/L) from 
the working solutions. Quantitation was performed using the Analyst® version 1.5.2 software (Applied 
Biosystems). During the chromatographic analysis, methanol blanks were injected between samples to 
prevent carry over. 
3.2.4 Method Detection Limits and Recoveries 
The method detection limits (MDLs) for the test compounds were assessed following the US EPA protocol 
(US EPA, 1997).  Seven one-liter river water samples were each spiked with the test compounds to a final 
concentration of 10 ng/L (per compound) and extracted similarly to the field samples. For the method 
recoveries, seven one-liter river water samples were each spiked with the test compounds to a final 
concentration of 20 ng/L (per compound) and extracted similarly to the field samples. 
3.3 Results  
3.3.1 MDLs and Recoveries 
Table 3-3 shows the method detection limits and recoveries for the test compounds. Detection limits in the 
river water ranged from 1.0 ng/L (sulfamethoxazole, lincomycin, and monensin) to 5.6 ng/L 
(sulfamethazine). Detection limits in the wastewater were assumed to be 5 times the detection limit in the 
river water since the volume of collected river samples was 5 times that of the effluent samples. Analyte 
recoveries from matrix-spiked samples were between 54-145%. 
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Table 3-3: Method Recoveries and Detection Limits (n = 7) 
 
Compound 
River Water 
MDL (ng/L) 
Wastewater 
MDL (ng/L) 
Recovery 
(%) 
Antimicrobials    
Sulfamethazine 5.6 28 84-145 
Sulfamethoxazole 1.0 5.0 54-91 
Trimethoprim 1.2 6.0 71-91 
Lincomycin
 
1.0 5.0 84-115 
Monensin 1.0 5.0 60-140 
Chemical Indicators    
Ibuprofen 2.2 11 67-145 
Venlafaxine 1.4 7.0 70-130 
Atrazine 1.2 6.0 62-92 
 
3.3.2 Detection Frequencies and Detection Levels 
Table 3-4 shows the detection frequencies, concentration ranges and mean concentrations of the target 
antimicrobials and chemical indicators in the river water samples and the wastewater effluent samples. In 
the river water samples, sulfamethoxazole had the highest detection frequency (84%) and mean 
concentration (36 ng/L), followed by trimethoprim (72%, with a mean concentration of 10 ng/L).  
Sulfamethazine was detected in 70% of the samples at a mean concentration of 16 ng/L, while lincomycin 
was detected at a higher concentration (21 ng/L) but only in a few samples (6.2%). Monensin was not 
detected in either the river water or effluent samples. For the chemical indicators, atrazine had the highest 
detection frequency (95%) and the lowest mean concentration (11 ng/L). Ibuprofen had the lowest 
detection frequency (64%) and the highest mean concentration (57 ng/L). The maximum antimicrobial 
concentrations measured in individual river water samples were 31 ng/L for sulfamethazine, 104 ng/L for 
sulfamethoxazole, and 29 ng/L for trimethoprim. For the chemical indicators, the highest measured 
concentration in individual samples was 146 ng/L for ibuprofen. 
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For the water samples from the tributaries, sulfamethoxazole was the most frequently detected 
antimicrobial (53%) but only at a very low mean concentration (4.7 ng/L). Trimethoprim was detected in 
fewer samples (20%) at an even lower mean concentration (2.6 ng/L). Sulfamethazine was detected in 
40% of the samples at a much higher mean concentration (72 ng/L). Lincomycin was not detected in the 
water samples from the tributaries. For the chemical indicators, atrazine was detected in all samples (mean 
concentration of 8.5 ng/L) while ibuprofen was not detected. Venlafaxine was detected in only 20% of the 
samples (mean concentration of 12 ng/L). The highest measured analyte concentrations in tributary 
samples were 98 ± 8.8 ng/L for sulfamethazine and 17 ± 1.6 ng/L for atrazine.   
 
For the effluent samples, sulfamethoxazole was detected in nearly all of the effluent samples (95%), 
followed by trimethoprim (57%) and to a lesser degree, by sulfamethazine (19%). Venlafaxine was 
detected in all samples while ibuprofen was detected in 76% of the samples and atrazine was not detected. 
It is interesting to note that except for sulfamethazine, the detected concentrations of the analytes in the 
effluents were significantly higher than their counterparts in the river samples. The mean concentrations of 
sulfamethoxazole and venlafaxine in the effluents was four times that of the main channel. In contrast, the 
mean sulfamethazine concentrations were highest in the tributaries (about twice of the effluent), and 
lowest in the main channel (about a third of the effluent).  
 
 51 
 
 
Table 3-4: Detection Frequencies and Mean Concentrations of Target Analytes
a
 
 
 
Compound 
Main Channel Samples Tributary Samples Wastewater Samples 
 Detection 
Frequency  
Range 
(ng/L) 
Mean 
(ng/L) 
Detection 
Frequency  
Range 
(ng/L) 
Mean 
(ng/L) 
Detection 
Frequency 
Range 
(ng/L) 
Mean 
(ng/L) 
Antimicrobials          
Sulfamethazine 70% < MDL
b
 – 31 16 ± 6.3 40% < MDL – 108 72 ± 26 19% < MDL – 55 43 ± 7.7 
Sulfamethoxazole 84% < MDL – 104 36 ± 22 53% < MDL – 15 4.7 ± 3.5 95% < MDL – 446 120 ± 119 
Trimethoprim 72% < MDL – 29 10 ± 5.6 20% < MDL – 3.6 2.6 ± 0.7 57% < MDL – 65 57 ± 3.3 
Lincomycin 6.2% < MDL – 35 21 ± 13 0% < MDL    < MDL 0% < MDL < MDL 
Monensin 0% < MDL < MDL 0% < MDL < MDL 0% < MDL < MDL 
Chemical Indicators          
Ibuprofen 64% < MDL – 146 57 ± 31 0% < MDL < MDL 76% < MDL – 440 102 ± 145 
Venlafaxine 86% < MDL – 78 21 ± 18 20% < MDL – 14 12 ± 1.6 100% 15 – 362 162 ± 107  
Atrazine 95% < MDL – 28 11 ± 4.8 100% 2 – 18 8.5 ± 4.9 0% < MDL < MDL 
 
a 
Sample means were calculated only for data from samples where analytes were detected (above MDL), while detection frequencies and ranges were calculated 
using data from all samples.   
b
 < MDL – below method detection limit. 
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3.3.3 Occurrence of Antimicrobials in the Watershed 
Figure 3-2 shows the mean concentrations of the frequently detected antimicrobials in the water samples 
taken from the main channel. The confluences of the sampled tributaries with the main channel as well as 
the entry points of the wastewater effluents are also indicated in the inset figure. 
 
In the main channel, the headwaters (locations G1-G4) are generally pristine with respect to 
antimicrobials, as indicated by their non-detection in the upstream sampling sites. The detection of 
sulfamethoxazole at a very low concentration (5.9 ± 2.8 ng/L) in location G2 (19 km downstream) may be 
due to the discharge from a very small (1.1 MLD) tertiary wastewater treatment plant located 29 km 
upstream (not sampled in this survey). The antimicrobial concentrations begin to rise in urban areas 
following discharges from wastewater treatment plants and downstream of several agricultural tributaries. 
The detected antimicrobial levels are below the 1 μg/L threshold (for water) for a Phase II risk assessment 
specified by the CVMP (EMEA, 2000). The veterinary antimicrobial, sulfamethazine, was detected more 
frequently downstream of the confluence of the main channel with the Conestogo River, which is the 
primary stream in the Conestogo sub-basin. The Conestogo sub-basin supports a relatively higher cattle 
and poultry population density compared to the rest of the watershed (see Table 2-3 in Chapter 2). There 
was also a notable increase in sulfamethazine concentrations past the Nith River, the main tributary in the 
Nith watershed, which also supports a high livestock population. Sulfamethoxazole and trimethoprim 
concentrations increased past the effluent discharge point (G4) of the first measured wastewater treatment 
plant (0.8 MLD), and even more after the second measured wastewater treatment plant (42 MLD, river 
sampling location G10) to further downstream of the main channel. The sulfamethoxazole concentrations 
increased more markedly than the trimethoprim concentrations, which fluctuated around the value detected 
just after the discharge point of the second treatment plant. 
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Figure 3-2: Concentrations of Antimicrobials in the Main Channel. Insert (top figure) Indicates 
Sampling Locations (dots) Confluence with Tributaries (triangles) and Entry points of Wastewater 
Effluent (stars). SMZ is Sulfamethazine, SMX is Sulfamethoxazole, and TRI is Trimethoprim. Error 
Bars Indicate ± Standard Deviation of Three Samples From Each Transect. 
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Figure 3-3 shows the measured concentrations of the antimicrobials in the five tributaries (Canagagigue 
Creek in the Upper Middle Grand sub-basin, Conestogo River in the Conestogo sub-basin, Speed River in 
the Speed sub-basin, Nith River in the Nith sub-basin, and Whiteman’s Creek in the Whiteman’s Creek 
sub-basin). Measured sulfamethazine concentrations were highest in the Conestogo and Nith Rivers. The 
corresponding sub-basins of these tributaries are largely agricultural, with the Nith sub-basin having the 
highest swine density among all sub-basins in the entire watershed (Table 2-3 in Chapter 2). 
Sulfamethoxazole was also measured in the other three tributaries (Conestogo River, Speed River, and 
Whiteman Creek) but only at very small concentrations compared to measurements from the main channel. 
A total of 13 municipal wastewater treatment plants, ranging in size from 0.13 to 54 MLD, discharge 
treated effluent to these tributaries (one in Canagagigue Creek, four in the Conestogo River, two in the 
Speed River, six in the Nith River, and none in Whiteman’s Creek). Of these treatment plants, only 
effluents from the two treatment plants in the Speed River were sampled in this survey study. 
 
Figure 3-3: Concentrations of Antimicrobials in the Tributaries (CC1 is Canagagigue Creek, C1 is 
Conestogo River, S1 is Speed River, N1 is Nith River, and W1 is Whiteman Creek). SMZ is 
Sulfamethazine, SMX is Sulfamethoxazole, and TRI is Trimethoprim. Error Bars Indicate ± 
Standard Deviation of Three Samples From Each Transect. 
 
3.3.4 Occurrence of Antimicrobials in the Wastewater Effluents 
Figure 3-4 shows the antimicrobial concentrations in the effluents from seven wastewater treatment plants 
(WWTP1 to WWTP5 discharge to the main channel; WWTP6 and WWTP7 discharge to the Speed River). 
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The sulfamethazine concentrations in the effluents from WWTP1 to WWTP7 were small (all below MDL) 
except for two effluents (WWTP2, 46 ± 9.3 ng/L, in the main channel and WWTP7, 40 ± 4 ng/L in the 
Speed River tributary). Sulfamethoxazole and trimethoprim concentrations were higher in three treatment 
plants in the main channel (WWTP3-WWTP5) and in one treatment plant in the Speed River (WWTP7). 
The highest measured mean concentrations of sulfamethoxazole were 355 ± 126 ng/L and 199 ± 13 ng/L 
for WWTP4 and WWTP3, respectively, while for trimethoprim, the highest measured mean concentrations 
were 61 ± 3.7 ng/L and 58± 2.1 ng/L for WWTP3 and WWTP7, respectively.   
 
Figure 3-4: Concentrations of Antimicrobials in the Effluents. Discharge Points for WWTP1 to 
WWTP5 are Located Within the Main Channel While Discharge Points for WWTP6 and WWTP 7 
are Within the Speed River. Whiteman Creek). SMZ is Sulfamethazine, SMX is Sulfamethoxazole, 
and TRI is Trimethoprim. Error Bars Indicate ± Standard Deviation of Three Replicate Samples. 
 
3.4 Discussion 
3.4.1 Detection of Antimicrobials in the Water 
In this study, the antimicrobial concentrations measured in the effluent and river samples are several orders 
of magnitude lower than the 1 μg/L threshold set by the CVMP (101 to 103 lower). This threshold is based 
on a retrospective review of ecotoxicity data submitted in environmental assessments for public display; 
above this value, further risk assessment (Phase II) is recommended (EMEA, 2000; CDER, 1997). The 
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measured concentrations are also comparable to values that have been reported in previous studies (Table 
3-5). The trimethoprim concentrations measured in the effluents are similar to the measured values for six 
wastewater treatment plants in the Lake Simcoe Watershed, a smaller watershed also located within the 
Southern Ontario region (Metcalfe, 2014). However, sulfamethoxazole concentrations are significantly 
higher (10
2
 higher). The measured antimicrobial concentrations in this study differ from values previously 
reported by Lissemore et al. (2006) for the same watershed. Most notably, in this study, the veterinary 
antimicrobial monensin was not detected in the river samples while lincomycin was detected in very few 
samples (6%). In contrast, the previous study reported a higher detection frequency for these compounds 
(75% and 91%, respectively, for monensin and lincomycin). It should be noted that the study by Lissemore 
et al. involved temporal water sampling in only 8 locations while the current study involved one-time 
sampling in 32 river and tributary locations.  
Table 3-5: Reported Antimicrobial Concentrations in River Water and Wastewater Effluent 
 
 
It is interesting to note that sulfamethazine, which is prescribed in Canada for use only in veterinary 
medicine (McEwen, 2002), was also detected frequently in wastewater effluents. This may be due to 
infiltration or contaminated overflows reaching the treatment plants. However, the detection of 
Sulfamethazine Sulfamethoxazole Trimethoprim Lincomycin Monensin
Source n (ng/L) (ng/L) (ng/L) (ng/L) (ng/L) Ref.
River Zhujiang (China) 14 23 3.1 170 nm nm 1
Across USA 104 220 150 150 60 nm 2
Across Germany 52 nd 30 nd nm nm 3
Rio Grande (USA) 3 nm 300 nd nd nd 4
Grand River Watershed (Canada) 125 3.2 2.8 2.7 12 44 5
Grand River Watershed (Canada) 96 16 36 10 21 nd 6
a
Wastewater Effluent Guangzhou (China) 6 120 22 320 nm nm 1
Across Germany 10 nd 400 320 nm nm 3
Albuquerque (USA) 7 nm 310 180 nd nd 4
12 nd 68 11 nd nm 7
7 nm 2.2 49 nm nm 8
Grand River Watershed (Canada) 21 42 120 57 nd nd 6
nd = not detected     nm = not measured     a) Main channel only   
1) Yang et al., 2011      2) Kolpin et al., 2002     3) Hirsch et al., 1999     4) Brown et al., 2006     5) Lissemore et al., 2006
6) This study     7) Glassmeyer et al., 2005     8) Metcalfe, 2014 (mean values calculated from reported data)
Location
Across USA 
Lake Simcoe Watershed (Canada)
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sulfamethazine in treatment plant effluents is not rare. Sulfamethazine has also been detected in treated 
effluents in countries where this compound is used primarily in livestock (Guerra et al., 2014; Pérez et al., 
2005).  
3.4.2 Impact of Wastewater Treatment 
The higher removal rates of pharmaceuticals, including antimicrobials, have been associated with greater 
degree of wastewater treatment, for example, advanced oxidation processes such as ozonation (Esplugas et 
al., 2007). In this study, lower effluent concentrations of the antimicrobials (sulfamethazine, 
sulfamethoxazole, trimethoprim) and chemical indicators (ibuprofen and venlafaxine) were measured from 
WWTPs with advanced treatment processes (Table 3-6).  Sulfamethazine was not detected in the effluents 
of WWTP 1 and WWTP 6, which both have tertiary treatment. In contrast, sulfamethazine concentrations 
were higher in effluents from treatment plants that only have conventional activated sludge treatment 
(WWTP 2 and WWTP 7). Similarly, sulfamethoxazole and trimethoprim concentrations were also higher 
in the plants with secondary treatment systems. Effluent levels of ibuprofen and ammonia (see Appendix 
B) also follow a similar trend as the antimicrobials concentrations.  
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Table 3-6: Characteristics of Study Wastewater Treatment Plants 
Plant 
Treatment 
Level Process 
Receiving 
Water 
Population 
Served 
Average 
Flow 
(m
3/d) 
WWTP 1  Tertiary Extended Aeration Grand River 2,726 800 
WWTP 2  Secondary 2-Stage Conventional 
Activated Sludge 
Grand River  129,502 42,000 
WWTP 3 Secondary Conventional 
Activated Sludge 
Grand River  231,866 65,700 
 WWTP 4 Secondary Conventional 
Activated Sludge 
Grand River  20,699 8,400 
WWTP 5 Secondary Advanced Activated 
Sludge 
Grand River  84,840 32,200 
WWTP 6 Tertiary Rotating Biological 
Contactors 
Speed River 134,894 46,000 
WWTP 7  Secondary Modified High Rate 
Activated Sludge
a
 
Speed River  24,824 6,600 
 Data from the Region of Waterloo Wastewater Treatment Master Plan Final Report (2007) 
 
a
 WWTP 7 is an extended aeration plant but is operated as a conventional activated sludge process 
3.4.3 Agriculture and Wastewater Inputs in the Receiving Water 
Over-all, there was an increasing trend in antimicrobial concentrations in the Grand River from the 
headwaters to near its discharge point to Lake Erie (Figure 3-2). The more notable increases occurred 
beginning in the central region of the watershed (starting at location G7 in Figure 3-1). The concentrations 
of the veterinary antimicrobial sulfamethazine spiked downstream of the channel’s confluences with 
agriculture-impacted tributaries (Conestogo and Nith Rivers). Although there are wastewater treatment 
plants upstream of the sampling locations in these tributaries, these have small capacities (0.1 – 2.7 MLD) 
and are unlikely the main sources of the sulfamethazine in the receiving stream. Effluents from these 
treatment plants were not sampled in the current study. However, data from the sampled WWTP effluents 
indicate that sulfamethazine concentrations are generally much lower than either sulfamethoxazole or 
trimethoprim concentrations (Table 3-4). Therefore, spikes in sulfamethazine concentration in the river are 
likely due to agricultural or other non-point sources.    
 
 59 
 
On the other hand, the spikes in sulfamethoxazole and trimethoprim concentrations in the main channel 
occur just downstream of effluent discharge points. The concentrations of these compounds in the effluents 
of the treatment plants located along the main channel were also relatively high. Taking into account the 
capacities of the treatment plants, these data suggest that the sulfamethoxazole and trimethoprim in the 
main channel likely come from point sources. 
 
In the main channel, the levels of ibuprofen, venlafaxine, nutrients, and chloride also exhibited notable 
increases just downstream of effluent discharges (Appendix B). Based on the higher concentrations of 
these chemicals in the effluents, it can be inferred that the WWTPs are the main sources of these chemicals 
in the main channel. 
3.4.4 Correlations among Antimicrobials, Chemical Indicators, Chloride, and Nitrogen 
A multivariate analysis of the mean concentrations (antimicrobials, chemical indicators, nutrients, and 
chloride) was performed to determine correlations among the detected chemicals in the river and effluent 
samples (Appendix D). Correlation coefficients (R
2
 with p < 0.001) were calculated using the Data 
Analysis toolkit in Microsoft Excel
®
.  
 
In river samples, the human antimicrobials sulfamethoxazole and trimethoprim were well correlated with 
each other and with venlafaxine (R
2
 > 0.7), suggesting that venlafaxine may be a good indicator for these 
antimicrobials (co-occurrence in river samples). Sulfamethazine was poorly correlated with other 
measured compounds (R
2
 of 0.7 – 0.33). Nutrients were also correlated to chemical indicators, some 
antimicrobials, as well as to other nutrients in river samples. Total ammonia was correlated to ibuprofen 
(R
2
 = 0.87) and nitrite was correlated to trimethoprim (R
2
 = 0.75). Dissolved chloride was correlated to 
nitrite and nitrate at R
2
 = 0.74 and R
2
 = 0.72, respectively. In the wastewater, sulfamethoxazole and 
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trimethoprim were highly correlated (R
2
 = 0.74) probably because they are often prescribed together 
(Grande et al., 2001). Venlafaxine was also correlated to sulfamethoxazole and trimethoprim at R
2
 = 0.82 
and R
2
 = 0.72, respectively. Total ammonia was correlated only to sulfamethazine (R
2
 = 0.92). As seen in 
Figure 3-4, sulfamethazine was detected only in the WWTPs with poorer treatment, which is a similar 
trend observed for total ammonia.  
 
The antimicrobials were poorly correlated with atrazine. As an herbicide, atrazine may be a good indicator 
of non-point source pollution due to its use for weed control in lawns. However, in this study, atrazine was 
not a suitable indicator for non-point source antimicrobials from farms. While atrazine was not detected in 
treatment plant effluents where neither lincomycin nor monensin was detected, it was also measured 
throughout the watershed where neither antimicrobial was found. These results indicate that atrazine may 
be a suitable marker for select contaminants from nonpoint sources (e.g., agriculture and land 
development) but not necessarily for the veterinary antimicrobials investigated in this study. The 
widespread low atrazine concentrations of atrazine in the river may be due to the seasonal application of 
atrazine, usually in spring, in non-agricultural areas such as golf courses (Winter and Dillon, 2005).  
3.4.5  Temporal Variabilities  
The results of the biweekly sampling in the Nith River and near its confluence with the main channel show 
variability from the results obtained during the one-time watershed-scale spatial sampling (Appendix C).  
Sulfamethazine was detected at lower concentrations (9 - 65 ng/L) during the biweekly sampling compared 
to the large-scale sampling (98 ± 8.8 ng/L). This variability highlights the role of timing during field 
sample collection for monitoring purposes. The large-scale spatial sampling in this study was conducted 
late in the fall season to coincide with the period when farmers typically spread manure fertilizer in the 
crop farms. The two sampling days also occurred after a rain event the previous days when antimicrobials 
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may have leached from soils and were rapidly flushed into the rivers. Except for a single trimethoprim 
measurement just slightly above the MDL (1.4 ng/L), sulfamethoxazole and trimethoprim were generally 
not detected during the biweekly sampling in the Nith River tributary. However, both were detected in the 
Grand River (confluence locations) but only at very low concentrations (sulfamethoxazole, 4.2 ± 2.8 ng/L; 
trimethoprim 5.8 ± 2.7 ng/L). 
3.4.6 Implications for Water Resources Management 
The data trends from this study demonstrate that both point and non-point sources influence the 
concentration profiles of antimicrobials in the Grand River Watershed. While the watershed is largely 
agricultural, the contribution of wastewater discharges to antimicrobial loads is also comparatively 
significant. This finding is consistent with other studies that indicate significant contributions of 
antimicrobials from point sources in largely agricultural watersheds (Iglesias et al., 2014; Brown et al., 
2006; Hirsch, 1999). From the perspective of AMR risk assessment, this finding implies that contributions 
of antimicrobials from point and non-point sources should be treated with equal importance despite clear 
indications that agriculture is the primary land use within the watershed. The results of the temporal 
sampling also highlight the significance of accounting for seasonal changes in antimicrobial loads. 
Antimicrobials inputs from farms may appear as pulse inputs especially right after rain events and during 
the land tilling seasons. However, inputs from wastewater discharges tend to be generally constant 
throughout the year, although minor fluctuations may be expected as a result of fluctuations in treatment 
efficiency during the cold and warm seasons. 
3.5 Chapter Summary and Future Work 
This study provides empirical data on the occurrence of antimicrobials in a mixed-use watershed.  
Research findings provide useful information and insights for assessing the risks associated with the high 
consumption of antimicrobials in human medication and in the livestock industry. The measured 
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antimicrobial concentrations were comparable to findings from other studies of similar watersheds and 
treatment plant effluents. All measurements were below the 1 μg/L threshold for a Phase II risk assessment 
set by the CVMP. Antimicrobials concentrations increased downstream of treatment plant outfalls and 
discharges from agricultural tributaries. Wastewater effluents were the primary sources of human 
antimicrobials (sulfamethoxazole and trimethoprim) in the main channel, while agricultural tributaries 
were the primary sources of the veterinary antimicrobial, sulfamethazine.  
 
Further research should explore the temporal variabilities in the antimicrobial levels in the watershed. 
While it can be expected that there are typically greater temporal fluctuations in non-point source inputs of 
veterinary antimicrobials compared to inputs of point-source human antimicrobials, these trends might not 
be observed in the Grand River in the coming years. It is anticipated that new and tighter regulations on the 
use of veterinary antimicrobials will soon take effect in Canada. Also, several wastewater treatment plants 
in the Grand River Watershed either have been recently upgraded or will be upgraded in the next three 
years. The findings of this study can serve as baseline for determining the effects of these new legislations 
and infrastructure upgrades on the occurrence of antimicrobials in the watershed.  
  
 63 
 
Chapter 4: Conclusion and Future Work 
In Chapter 1 of this manuscript, a comprehensive literature review was performed to identify some of the 
knowledge gaps pertaining to the global use, environmental occurrence, and regulations on the 
consumption and distribution of antimicrobials.  The potential for developing resistant traits in pathogens 
is the most significant health risk associated with the widespread use of antimicrobials and their 
persistence in the environment. Quantifying this risk can assist policy makers in formulating corresponding 
mitigation strategies, however, the risk analyst faces the challenge of varying regulations among countries 
and the lack of available data on antimicrobials consumption. The current study contributes knowledge to 
this research gap by providing preliminary data on the occurrence and distribution of select antimicrobials 
in the environment through modeling and empirical data collection. The study addresses the following 
specific objectives: 
(i) development of a mass load estimation model for determining the residual levels of veterinary 
antimicrobials in the environment, discussed in Chapter 2; and 
(ii) analysis of the patterns of occurrence of relevant antimicrobials in a mixed use watershed, 
discussed in Chapter 3. 
The mass load estimation model (Equation 1) presented in Chapter 2 has been verified with literature from 
and was applied to a case study of four veterinary antimicrobials (lincomycin, monensin, oxytetracycline, 
and sulfamethazine) in the Grand River Watershed in Ontario, Canada. Results of the model application 
suggest that the estimated residual concentrations of each target compound do not exceed the toxicity 
threshold for soil (100 μg/kg) for a Phase II risk assessment as recommended by the Committee for 
Medicinal Products for Veterinary Use (CVMP). The proposed estimation model can be used as a 
screening tool to assess the risks associated with the widespread use of antimicrobials in livestock farms, 
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and the potential effects of applying livestock manure to soil. It can also complement mass transport 
models in the study of the environmental attenuation of residual antimicrobials. 
In Chapter 3, the occurrence of antimicrobials in the Grand River Watershed in Southern Ontario, Canada 
was studied by collecting a total of 117 water samples from 7 wastewater treatment plants and 32 sampling 
locations in the main river channel and in five tributaries.  The samples were analyzed for five priority 
antimicrobials (human and veterinary), namely: lincomycin, monensin, sulfamethazine, sulfamethoxazole, 
and trimethoprim. The concentrations of antimicrobials in the main river channel generally increased 
downstream of wastewater treatment plants. Concentrations of the veterinary antimicrobial sulfamethazine 
also increased in the vicinity downstream of agricultural areas. The findings from this reconnaissance 
survey indicate that the antimicrobial concentrations in the water are below the 1 μg/L threshold set by the 
CVMP for a Phase II risk assessment. These findings also indicate that predominantly agricultural 
watersheds are a source of veterinary antimicrobials in the main river channel. Results of the biweekly 
water sampling in the Nith River highlight the temporal variability in the concentrations of antimicrobials, 
suggesting that temporal sampling is necessary in monitoring the environmental fate of residual 
antimicrobials.  
 
In Canada, it is anticipated that new and tighter regulations on the use of veterinary antimicrobials will 
take effect in the coming years. Also, several wastewater treatment plants in the watershed either have 
been recently upgraded or will be upgraded in the next three years. The findings of this study can serve as 
baseline for determining the effects of these regulatory changes and infrastructure improvements on the 
spread of antimicrobials in the Grand River Watershed.  
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Future related work can be explored in the following areas:  
(i) Improvements in the mass load model. Degradation as a result of manure storage, composting, or 
in-soil biochemical degradation can be accounted for in the proposed mass load estimation model 
presented in Chapter 2 by incorporating kinetics terms, for example, first-order or pseudo-first 
order degradation. A more robust method for estimating livestock densities can also be performed 
by accounting for variabilities in individual farm sizes where such data are available. However, 
these improvements should be weighed against the simplicity and ease of use of the current model; 
 
(ii) Regular spatial and temporal monitoring of antimicrobial concentrations in the main river channel 
and in the agricultural tributaries. As previously noted, the data and findings from the current 
study can be used to compare the effects of future legislations and wastewater treatment plant 
upgrades, and regular monitoring will establish if any environmental improvements are observed 
over time; and 
 
(iii) Sampling for antimicrobials in other environmental matrices: sludge, livestock manure, soil, and 
river sediments. Some antimicrobials (e.g., tetracycline) have a higher affinity for solids than the 
aqueous phase.  In combination with environmental persistence, this chemical property may 
indicate that the soil matrix can act as a reservoir for antimicrobials and consequently, 
antimicrobial resistance. 
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Appendix A: Validation Methodology 
This appendix serves as a guide to provide further understanding as to how the model is used to 
estimate veterinary antimicrobial concentrations. The discussion provided in this appendix focuses on 
variable acquisition and the arguments for variable use within the validations and case study 
presented in Chapter 2 of this thesis.  
 
The validations were performed using sulfamethazine and oxytetracycline data for swine and poultry 
from Wang et al., (2014) and sulfamethazine concentrations for swine from Zhou et al., (2013). This 
section discusses how values were chosen for variables in Equation 1 for the sulfamethazine 
calculation from Wang et al., (2014). The Zhou et al., (2013) and CVMP comparison portions of the 
validation was calculated in a similar manner.  
PECs = (
D x T x B x L x Fℎ x  𝐹𝑒 
 ρ𝑠 x d
𝑥 
𝐴𝑝
𝐴𝑓
) C   Equation 1 
 
Antimicrobial dosage (D) is the amount of sulfamethazine measured in feed (4.58 μg/kg) multiplied 
by the mass of feed consumed by a swine per day (2.5 kg/day). These values were used as presented 
by Wang et al., (2014). The number of treatment days (T) was found to be the number of days that it 
takes the herd to produce the manure spread with the smallest value being one (Equation 8). T was 
taken to be one for swine and two for poultry (Table A-1). The mass of manure spread was divided by 
the multiplication of three terms: the amount of manure produced by the livestock species, the rate of 
manure production and percent dry matter. In this validation, 25,000 swine excreted 6625 kg of 
manure in one day at a rate of 2 kg/day and 23% dry mass (Wang et al., 2014). A livestock density 
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(L) of 25,000 swine were used to calculate PECs. The body weight of the swine was assumed to be 
106 kg, the average of the three hog groups in the CVMP (EMEA, 2008). If greater refinement is 
desired one can calculate an estimate from all three hog age groups and sum the estimates to get a 
refined estimate total for PECs.  
 
The fraction of manure spread per area (Fa) takes into account whether all of the manure is spread 
from the livestock pens onto a field. The units for this term are hectaresfarm pens
 
divided by hectaresfield. 
If the density of the livestock is already in livestock/hectaresfield, the Fa term can be one, as it is in 
Validation 1. The fraction of the herd being treated (Fh) was one as the paper makes no mention of 
different feeds for different hog growth stages. Similarly, the fraction excreted (Fe), the amount of 
sulfamethazine excreted by swine of the original compound, is also one despite being metabolized in 
the liver of swine. This is because sulfamethazine components inactivated in swine’s liver by attached 
sugars can be reactivated by environmental bacteria when the sugars are consumed (Sarmah et al., 
2006). Thus, sulfamethazine metabolites cannot be discounted following excretion. Bulk soil density 
(𝝆s), is 1150 kg m
3
 (Wang et al., 2014). The depth of top soil (d) that manure infiltrated was 0.10 m, 
an average of the 0-0.2m of topsoil sampled (Wang et al., 2014). The conversion factor (C) was 1 
hectare per 10,000 m
2
. The PECs estimate for the Wang et al., (2014) hog farm is 26.38 μg/kg 
compared to the Wang et al., (2014) topsoil measurement of 18.89 ± 6.40 μg/kg. The difference 
between the estimate and measured values is 7.5 μg/kg or 140%. 
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Table A-1: Percentage of Canadian Herds Treated with Antimicrobial and Excretion Rates of 
Antimicrobial by Livestock Type 
Antimicrobial 
Poultry Cattle Swine 
% herds 
treated
a
 % excreted 
% herds 
treated % excreted 
% herds 
treated % excreted 
Lincomycin N/A 83
b
 10
e
 - 42
h
 21
b
 
Monensin N/A 94
c
 76
e
 95
f
 - - 
Oxytetracycline N/A 100
d
 10
e
 100
d
 15
h
 100
d
 
Sulfamethazine N/A - 5
e
 26
g
 8
h
 52
i
 
 *Dash indicates not extensively used in animal with no data available. 
a. No herd use data available, Agunos et al., 2013     b.  Hornish et al., 1987     c.  Donoho et al., 1982  
d.  CVMP, 1995     e.  Carson et al., 2008     f.  Herberg et al., 1978.     g.  Nouws, 1992.   
h.  CIPARS, 2008        i.  Paulson et al., 1981. 
Table A-2: Livestock Specific Weights and Average Livestock Weights Used in the Model 
Livestock 
Individual Animal 
Body Weight (kg)
1
 
Average Body 
Weight (kg) 
Cattle  295 
Calf 140  
Cow 450  
   
Swine  106 
Weaner   12.5  
Fattening  65  
Sow (with litter) 240  
   
Chickens  1.3 
Broiler 1.0  
Layer 1.6  
1
Individual Body Weights taken from EMEA, 2008. 
Case Study 
The choices for three variables applied in the case study that differed from the validation variable 
acquisition method will now be discussed. These variables include the livestock density, soil bulk 
density, and fraction of herd treated. 
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The livestock density (L) in the case study was calculated as the summed county populations within a 
sub-basin area. Livestock populations were assumed to be equally distributed across the county
1
. The 
boundary of the Grand River Watershed and Ontario counties were overlaid to determine the 
percentage of county area within a sub-basin
2
. The area of the county within the watershed (taken as a 
percent) was multiplied by the county livestock population to obtain the number of livestock in the 
sub-basin contributed by that county. The fragmented livestock county populations were then 
summed within the sub-basin boundaries to form each sub-basin livestock population. This method of 
averaging livestock populations has been performed elsewhere in the research literature (Dorner et al., 
2006).  
The use of only one dry soil bulk densities were used due to their dominance in the top soil of most 
agricultural catchments (GRCA, 2008). The dry soil bulk density of Guelph loam (1550 kg m
-3
) soil 
was used (GRCA, 2008; Reynolds et al., 2002). The depth of manure penetration is the distance that 
the manure travels into the soil. This does not take incorporation or injection of manure into account 
but assumes surface level application with solid or liquid manure. Depth of manure penetration was 
assumed to be 0.10 m which is consistent with past studies (EMEA, 2008). A unit conversion factor is 
present in Equation 1 (C) and is equal to 0.1 in this case study. It is comprised of a factor of 1000 μg 
/mg in the numerator divided by 10,000 m
2
/ha in the denominator. 
The fraction of livestock herds treated with the select antimicrobial in Canada (Fh) was taken from 
CIPARS, (2008) for swine and Carson et al., (2008) for cattle for the case study. Currently there is no 
herd data available for poultry antimicrobial use due to a lack of national surveillance (Agunos et al., 
2013). Therefore, an assumption was made the antimicrobial is administered to all poultry herds. 
                                                     
1
 Livestock county population data was obtained from the Ontario Ministry of Agriculture and Food 
(OMAFRA) website titled “2011 Livestock by County and District at a Glance” with original data generated by 
Statistics Canada. 
2
 Watershed and county ArcGIS® layers were provided by the University of Waterloo GeoSpatial Centre. 
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Appendix B: Antimicrobial Concentrations for Grand River 
 
Site
Grand River Latitude Longitude Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev
G1 44.096377 -80.3735 < MDL - < MDL - < MDL - < MDL - < MDL - 4.2 0.6 < MDL - < MDL -
G2 43.990018 -80.374 < MDL - 5.9 2.8 < MDL - < MDL - < MDL - < MDL - 22 2.9 1.9 0.2
G3 43.942391 -80.3265 < MDL - < MDL - < MDL - < MDL - < MDL - 1.6 0.1 < MDL - 5.8 3.1
G4 43.892852 -80.3003 < MDL - < MDL - < MDL - < MDL - < MDL - 5.1 3.2 < MDL - 4.0 0.6
G5 43.862559 -80.273 < MDL - 18 1.4 5.1 0.3 < MDL - < MDL - 11 0.9 < MDL - 11 0.3
G6 43.725181 -80.3445 6.3 0.7 14 7.5 < MDL - < MDL - < MDL - 53 33 17 3.9 4.6 1.2
G7 43.637135 -80.4406 < MDL - 35 2.7 3.7 1.2 < MDL - < MDL - 10 0.5 < MDL - 13 2.9
G8 43.585202 -80.4824 < MDL - 22 12 3.5 1.5 < MDL - < MDL - 10 1.7 < MDL - 7.7 1.4
G9 43.505204 -80.4745 23 1.6 6.4 1.3 1.7 - < MDL - < MDL - < MDL - 42 - 19 8.8
G10 43.473609 -80.473 15 2.5 28 11 14 3.1 < MDL - < MDL - 18 4.5 146 67 14 0.7
G11 43.480235 -80.423 11 2.4 53 19 16 4.1 < MDL - < MDL - 54 7.1 99 36 13 2.2
G12 43.446298 -80.3959 29 16 12 5.1 5.3 1.0 2.0 - < MDL - 5.6 0.2 81 18 11 3.8
G13 43.421811 -80.4113 13 0.9 22 5.2 5.9 1.4 < MDL - < MDL - 17 0.6 65 18 23 5.6
G14 43.401992 -80.4296 < MDL - < MDL - < MDL - < MDL - < MDL - < MDL - < MDL - 9.3 0.8
G15 43.398063 -80.4156 15 2.4 83 30 24 4.8 < MDL - < MDL - 56 4.8 47 6.4 10 1.7
G16 43.394999 -80.4085 14 3.2 39 8.0 10 1.7 < MDL - < MDL - 10 3.0 68 7.8 8.9 2.6
G17 43.388404 -80.387 18 6.6 45 6.9 16 0.9 < MDL - < MDL - 17 1.1 80 21 13 3.3
G18 43.385963 -80.3676 17 0.6 47 3.7 17 2.2 < MDL - < MDL - 14 1.2 85 18 14 1.9
G19 43.385488 -80.3648 20 3.7 25 25 6.6 7.0 35 - < MDL - 13 3.8 55 38 12 4.6
G20 43.384609 -80.3564 8 1.3 16 2.2 < MDL - < MDL - < MDL - 1.9 0.1 16 - 11 0.7
G21 43.343442 -80.3171 17 4.3 33 6.7 11 1.1 < MDL - < MDL - 10 0.4 59 7.2 10 1.8
G22 43.317468 -80.3147 11 1.6 66 11 15 2.6 < MDL - < MDL - 41 0.9 40 22 9.4 1.1
G23 43.277158 -80.347 11 5.0 78 23 16 3.2 < MDL - < MDL - 47 6.1 44 7.0 9.2 2.7
G24 43.19511 -80.384 13 4.3 59 11 14 0.8 < MDL - < MDL - 48 2.7 33 - 18 7.0
G25 43.173667 -80.3534 26 5.8 28 6.4 7.1 1.6 < MDL - < MDL - 12 0.3 48 8.7 14 3.8
G26 43.149842 -80.2948 29 2.1 62 10 11 0.4 < MDL - < MDL - 44 2.1 28 4.5 10 0.3
G27 42.917841 -79.6555 13 1.1 32 6.4 6.1 0.3 22 13 < MDL - 11 0.8 63 33 20 10
Compound Concentrations (ng/L)
Venlafaxine Ibuprofen AtrazineSulfamethazine Sulfamethoxazole Trimethoprim Lincomycin Monensin
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Site
Tributaries Latitude Longitude Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev
CC1 43.58069 -80.5081 < MDL - < MDL - < MDL - < MDL - < MDL - < MDL - < MDL - 2.0 0.5
C1 43.52546 -80.5167 46 1.1 3.3 0.4 < MDL - < MDL - < MDL - < MDL - < MDL - 17 1.6
S1 43.391 -80.370249 < MDL - 5.7 1.2 2.6 0.9 < MDL - < MDL - 12 2.0 < MDL - 6.5 1.1
N1 43.19148 -80.3837 98 8.8 9.7 4.9 < MDL - < MDL - < MDL - < MDL - < MDL - 11 1.6
W1 43.13309 -80.3724 < MDL - < MDL - < MDL - < MDL - < MDL - < MDL - < MDL - 6.6 1.8
WWTPs
WWTP1 43.889403 -80.3108 < MDL - 15 1.4 < MDL - < MDL - < MDL - 110 0.7 15 - < MDL -
WWTP2 43.479573 -80.4822 46 13 12 1.2 < MDL - < MDL - < MDL - 17 2.0 52 3.7 < MDL -
WWTP3 43.400846 -80.4202 < MDL - 199 13 61 3.7 < MDL - < MDL - 119 7.5 37 8.6 < MDL -
WWTP4 43.386408 -80.3501 < MDL - 355 126 52 4.8 < MDL - < MDL - 349 11 53 6.0 < MDL -
WWTP5 43.338312 -80.3179 < MDL - 156 41 57 7.4 < MDL - < MDL - 240 30 30 2.4 < MDL -
WWTP6 43.52177 -80.264162 < MDL - 7.5 2.2 < MDL - < MDL - < MDL - 69 3.0 < MDL - < MDL -
WWTP7 43.42389 -80.329962 40 6 93 13 58 2.1 < MDL - < MDL - 228 3.2 426 24 < MDL -
Compound Concentrations (ng/L)
Sulfamethazine Sulfamethoxazole Trimethoprim Lincomycin Monensin Venlafaxine Ibuprofen Atrazine
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Appendix C: Antimicrobial Concentrations for Nith Sub-basin 
Sampling 
Antimicrobials 
 
< MDL indicates less than method detection limit.  
Dash indicates no standard deviation available (n < 2). 
 
 
< MDL indicates less than method detection limit.  
Dash indicates no standard deviation available (n < 2). 
 
 
Site Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev
A < MDL - 17 3.0 13 4.1 27 5.4 48 21
B < MDL - 28 3.0 25 7.3 31 6.1 < MDL -
C < MDL - 15 2.8 25 - 26 2.1 < MDL -
D < MDL - 17 9.4 29 3.4 < MDL - < MDL -
G24 < MDL - 16 2.2 11 1.1 65 27.5 8.8 -
G25 < MDL - < MDL - 10 1.5 48 6.4 9.2 0.8
Sulfamethazine Temporal Sampling
Sept. 30 Oct. 21 Nov. 6 Nov. 19 Dec. 6
Site Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev
A < MDL - < MDL - < MDL - < MDL - < MDL -
B < MDL - < MDL - < MDL - < MDL - < MDL -
C < MDL - < MDL - < MDL - < MDL - < MDL -
D < MDL - < MDL - < MDL - < MDL - < MDL -
G24 < MDL - 5.0 1.4 2.1 0.3 1.4 0.1 8.6 1.2
G25 < MDL - 4.8 0.9 1.9 0.4 1.8 0.5 7.6 0.7
Sulfamethoxazole Temporal Sampling
Sept. 30 Oct. 21 Nov. 6 Nov. 19 Dec. 6
Site Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev
A < MDL - < MDL - 1.4 - < MDL - < MDL -
B < MDL - < MDL - < MDL - < MDL - < MDL -
C < MDL - < MDL - < MDL - < MDL - < MDL -
D < MDL - < MDL - < MDL - < MDL - < MDL -
G24 < MDL - 7.0 0.9 5.1 1.5 2.4 1.1 9.9 0.9
G25 < MDL - 5.6 0.3 5.2 0.7 2.4 0.6 9.0 0.4
Trimethoprim Temporal Sampling
Sept. 30 Oct. 21 Nov. 6 Nov. 19 Dec. 6
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< MDL indicates less than method detection limit.  
Dash indicates no standard deviation available (n < 2). 
 
< MDL indicates less than method detection limit.  
Dash indicates no standard deviation available (n < 2). 
 
 
< MDL indicates less than method detection limit.  
Dash indicates no standard deviation available (n < 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Site Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev
A < MDL - < MDL - < MDL - 16 7.0 86 5.7
B < MDL - < MDL - < MDL - 78 25 26 22
C < MDL - < MDL - < MDL - 82 14 5.9 1.6
D < MDL - < MDL - < MDL - < MDL - < MDL -
G24 < MDL - < MDL - < MDL - < MDL - < MDL -
G25 < MDL - < MDL - < MDL - < MDL - < MDL -
Lincomycin Temporal Sampling
Sept. 30 Oct. 21 Nov. 6 Nov. 19 Dec. 6
Site Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev
A < MDL - < MDL - < MDL - < MDL - < MDL -
B < MDL - < MDL - < MDL - < MDL - < MDL -
C < MDL - < MDL - < MDL - < MDL - < MDL -
D < MDL - < MDL - < MDL - < MDL - < MDL -
G24 < MDL - < MDL - < MDL - < MDL - < MDL -
G25 < MDL - < MDL - < MDL - < MDL - < MDL -
Monensin Temporal Sampling
Sept. 30 Oct. 21 Nov. 6 Nov. 19 Dec. 6
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Chemical Indicators 
 
< MDL indicates less than method detection limit.  
Dash indicates no standard deviation available (n < 2). 
 
 
< MDL indicates less than method detection limit.  
Dash indicates no standard deviation available (n < 2). 
 
< MDL indicates less than method detection limit.  
Dash indicates no standard deviation available (n < 2). 
 
Site Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev
A < MDL - < MDL - < MDL - 6.0 1.1 < MDL -
B < MDL - < MDL - < MDL - 18 11 < MDL -
C < MDL - < MDL - < MDL - 5.4 0.6 < MDL -
D < MDL - < MDL - < MDL - 5.5 - < MDL -
G24 < MDL - < MDL - 38 13 16 5.7 39 6.6
G25 < MDL - < MDL - 45 12 19 6.6 < MDL -
Ibuprofen Temporal Sampling
Sept. 30 Oct. 21 Nov. 6 Nov. 19 Dec. 6
Site Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev
A < MDL - < MDL - < MDL - < MDL - < MDL -
B 18 1.7 < MDL - 2.0 - < MDL - < MDL -
C 6.1 1.4 1.9 0.3 1.4 - 1.5 - 1.9 1.7
D 2.4 0.2 1.6 0.2 < MDL - 2.2 0.6 3.2 0.3
G24 39 1.6 35 2.8 17 0.9 11 1.1 29 1.2
G25 36 3.2 26 3.6 19 1.3 9.1 0.8 28 0.2
Venlafaxine Temporal Sampling
Sept. 30 Oct. 21 Nov. 6 Nov. 19 Dec. 6
Site Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev Mean Std. Dev
A 41 5.6 32 3.3 16 0.7 12 1.5 20 -
B 36 10 43 34 14 3.1 14 1.7 16 -
C 20 2.4 23 1.6 23 4.2 11 1.1 8.4 0.3
D 28 12 20 1.5 20 0.6 10 0.6 3.9 -
G24 61 30 39 2.9 24 3.4 15 2.3 5.9 1.0
G25 48 16 35 8.1 23 1.5 14 0.8 4.6 0.5
Atrazine Temporal Sampling
Sept. 30 Oct. 21 Nov. 6 Nov. 19 Dec. 6
 84 
 
 
Appendix D: River Water and Wastewater Correlations 
River Water (p < 0.001)
 
Wastewater (p < 0.001) 
 
Sulfamethazine Sulfamethoxazole Trimethoprim Lincomycin Monensin Ibuprofen Venlafaxine Atrazine Total Ammonia Nitrite Nitrate Total Phosphorus Dissloved Chloride
Sulfamethazine 1.000
Sulfamethoxazole 0.050 1.000
Trimethoprim 0.019 0.915 1.000
Lincomycin 0.028 0.024 -0.010 1.000
Monensin N/A N/A N/A N/A 1.000
Ibuprofen 0.038 0.408 0.628 0.145 N/A 1.000
Venlafaxine -0.034 0.799 0.702 -0.072 N/A 0.280 1.000
Atrazine 0.325 0.298 0.328 0.332 N/A 0.362 0.099 1.000
Total Ammonia 0.008 0.276 0.492 -0.055 N/A 0.867 0.258 0.230 1.000
Nitrite 0.007 0.615 0.750 0.134 N/A 0.628 0.433 0.246 0.520 1.000
Nitrate 0.322 0.412 0.416 0.099 N/A 0.181 0.167 0.343 0.151 0.512 1.000
Total Phosphorus 0.204 0.150 0.310 -0.028 N/A 0.421 0.045 0.176 0.439 0.323 0.327 1.000
Dissolved Chloride 0.048 0.584 0.641 0.215 N/A 0.499 0.377 0.283 0.456 0.744 0.723 0.314 1.000
Sulfamethazine Sulfamethoxazole Trimethoprim Lincomycin Monensin Ibuprofen Venlafaxine Atrazine Total Ammonia Nitrite Nitrate Total Phosphorus Dissloved Chloride
Sulfamethazine 1.000
Sulfamethoxazole -0.268 1.000
Trimethoprim 0.028 0.743 1.000
Lincomycin -0.320 -0.358 -0.467 1.000
Monensin N/A N/A N/A N/A 1.000
Ibuprofen 0.702 -0.004 0.437 -0.248 N/A 1.000
Venlafaxine -0.158 0.824 0.723 -0.197 N/A 0.299 1.000
Atrazine -0.320 -0.389 -0.489 -0.167 N/A -0.248 -0.356 1.000
Total Ammonia 0.916 -0.395 -0.258 -0.242 N/A 0.364 -0.420 -0.242 1.000
Nitrite 0.680 -0.094 0.389 -0.199 N/A 0.991 0.206 -0.196 0.347 1.000
Nitrate -0.877 0.506 0.210 -0.057 N/A -0.457 0.461 0.418 -0.906 -0.472 1.000
Total Phosphorus 0.728 -0.008 0.454 -0.313 N/A 0.987 0.217 -0.244 0.407 0.986 -0.496 1.000
Dissolved Chloride 0.389 0.283 0.571 -0.919 N/A 0.543 0.324 0.165 0.174 0.505 0.033 0.576 1.000
